Entities

Edward (Eddie) Segel co-founded Floating Point with John Loser after working together at Bridgewater and on the founding team of Oscar Health, where they led product, data and risk.

John Loser co-founded Floating Point with Edward Segel. They previously built trading systems at Bridgewater and helped build Oscar Health, bringing public-market investment and company operating experience to the firm.

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board.

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board.

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board. Atlantic Bridge’s March22,2025 published directory identifies Osman Kent as Venture Partner. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Osman is a serial technology and media entrepreneur best known as the founder and CEO of 3Dlabs - at one time one of the fastest growing NASDAQ companies in Silicon Valley. 3Dlabs is a fabless chip company whose products were used in the making of films like the Titanic and The Matrix and helped pioneer the 3D graphics revolution on the PC. Osman is a Fellow of the Royal Society of Arts in the UK, has a First Class degree in Computer Science and Electronics Engineering from University of Birmingham (UK) and is the inventor of numerous patents in the field of computing and graphics

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board.

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board.

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board.

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board.

Atlantic Bridge’s March22,2025 published directory identifies Helen McBreen as Partner. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Helen joined Atlantic Bridge in 2015 on our University Bridge Fund. At Atlantic Bridge, Helen leads investing in early stage deeptech companies. With a strong track record built over 15 years, Helen has successfully sourced and financed over 40 deep tech ventures including notable Irish companies: Neurent Medical, Equal1, Siren, Output Sports, Proverum Medical, Plasmabound and Manna. Companies from Atlantic Bridge’s early stage portfolio have to date raised over €700m and continue to grow and scale globally. Helen is on the board of many venture backed companies and chairs the Governance Committee of IPIC , a Science Foundation Ireland Centre for photonics. Helen is both mentor and advisor to organisations including Knowledge Transfer Ireland, IVCA, UCD VentureLaunch, Start100 and is a prior VP at TechTour. Passionate about encouraging young people’s involvement in STEM, Helen is board member of the education focused non-profit, Kinia, and is a judge at the BT Young Scientist and Technology Competition. Helen is listed as one of the Top 100 Women in STEM in Ireland and is a Kauffman Fellow. Helen was awarded a 1st Class Hons. Electronic Engineering Degree (UCD) and a PhD (The University of Edinburgh) in the area of AI based conversational agents and multimodal interfaces.

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board.

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board.

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board.

Published as an EIC Fund company board representative; this is a portfolio-company governance role, not employment by the EIC Fund or membership of its own board.

Butterfly’s main team page publishes Tanya Horowitz, while its fund disclosure identifies the same partner as Tanya Marvin-Horowitz. She is Stockholm based.

Bianka Vargas serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Administration professional in the comptroller’s office of the Elizabeth Board of Education. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Cassandra Santos serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Chief technology officer of Caliber Collision, as identified in the dated filing. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Donna Smyth serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Paralegal at the Law Offices of Nicholas P. Scutari; appointedDecember2025 per primaryfiling. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Joseph Roberts serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Former speaker of the New Jersey General Assembly. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Ninfa Saunders serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Former president and chief executive of Navicent Health. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Diana Nole serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Former corporate vice president at Nuance, a healthcare speech and AI technology business. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

James Mitchell Jr. serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Founder of JMJ Advisors. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Vikki Pryor serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Founder, managing principal and president of Change Create Transform LLC. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Multiscale Technologies, operating as Multiscale AI, develops industrial AI software to optimize semiconductor materials, processes and manufacturing. Its platform combines physics-informed Bayesian digital twins with AI agents that curate fragmented fab data, run virtual experiments, investigate root causes and propose process windows. It integrates a metadata catalog, data curation, active learning, model execution and reusable workflows so engineering teams can adapt analyses across products, process nodes and manufacturing conditions. Natural-language interfaces let engineers request analyses while underlying models incorporate physical simulation, process sequences, measurement data and uncertainty. The company serves semiconductor fabs and manufacturing-material suppliers, with teams in Atlanta, San Francisco and Hyderabad. Micron Ventures publishes Multiscale Technologies as a portfolio investment; the company’s own current site also lists Micron among its investors.

OmniTier develops AI software, proprietary genomic-analysis algorithms and memory-accelerated computing appliances for precision-medicine research. Its on-premise CompStor platform covers secondary analysis of sequencing reads through variant calling, followed by annotation, prioritization and interpretation of genetic variants. CompStor Novos supports short- and long-read sequencing, while CompStor Insight provides variant interpretation and custom database workflows; CompStor Spectrum combines secondary and tertiary analysis in a standalone appliance. These systems let researchers, bioinformaticians and clinical organizations analyze exomes and whole genomes while retaining local control of patient data, supporting rare-disease research, population studies and pharmaceutical genomics. Founded in February 2015, the company is based in the San Francisco Bay Area. Micron Ventures lists OmniTier as a portfolio investment, and OmniTier’s own site publishes Micron among its partners and investors.

Carlos Medina serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Chairman of the Statewide Hispanic Chamber of Commerce and president of Robinson Aerial Surveys, Inc., as identified in the dated filing. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Co-founder of OmniTier. The company’s own April 18, 2023 product announcement identifies him as CEO and co-founder; the enduring founder relationship is recorded here because its current website does not publish a current executive roster.

Co-founder and CEO of Multiscale AI, confirmed by the company’s May 12, 2026 announcement. Georgia Tech faculty member whose research spans materials engineering, mechanics, manufacturing and data science, translating physics-informed AI research into industrial technology.

Co-founder and Chief Technology Officer of Multiscale Technologies, confirmed by his April 30 and May 4, 2026 company publications. Leads development of industrial AI software connecting materials, process and manufacturing expertise with digital twins and AI agents.

Brian Kinkead serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Retired vice chairman of the Global Healthcare Group at Bank of America Merrill Lynch. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Joseph Kyrillos serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Former New Jersey state senator and principal of SK Partners. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Kelly Stewart Maer serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Former director of public affairs at Capital Health System. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Leonard Coleman serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Former president of the National League of Professional Baseball Clubs. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Leonard Feld serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. President of Leonard G. Feld, MD, LLC and retired president of Pediatric Specialists of America. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Paul Juliano serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Former president and CEO of the New Jersey Sports and Exposition Authority. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Stephanie Lagos serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Former chief of staff to the First Lady of New Jersey; appointed to Horizon board inDecember2025 per primaryfiling. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Geoffrey Arlen serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Founder of Arlen Law Firm, LLC. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Ralph Caputo serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Former New Jersey Assemblyman. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Todd Brown serves on Horizon Mutual Holdings, Inc.’s board according to the year-end2025 primary regulator filing certifiedMay26,2026. Lead independent director of Horizon Mutual Holdings; earlier vice chairman of ShoreBank Corporation, now retired from that outside job. This is a corporate governance affiliation, not a claim that every director is a venture investment employee or personally funded the parent’s portfolio. Outside positions are qualified to that dated primary filing.

Alison Banks-Moore is vice president and chief diversity officer at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Corporate diversity leader named in the primary parent employee disclosure. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Douglas Falduto is vice president, administration and chief security officer at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Administration and enterprise security leader named in the primary parent employee disclosure. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Kenny Kan is vice president and chief actuary at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Actuarial leader named in the primary parent employee disclosure. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Aisha Thomas-Petit is senior vice president and chief human resources officer at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Leads workforce strategy, talent acquisition, organizational development, compensation, employee relations, leadership development and training. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Jamie Reedy is senior vice president, health solutions at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Healthcare solutions leader named in the primary parent officer/employee disclosure. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Jennifer Velez is executive vice president, health and network solutions at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Oversees network and care delivery solutions, value-based programs, clinical operations, pharmacy, behavioral health, and clinical analytics and medical economics. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Joseph Albano is vice president, commercial and specialty markets at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Commercial and specialty insurance markets leader named in the primary parent employee disclosure. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

David Rosenberg is executive vice president and chief financial officer at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Manages the financial risks of the enterprise and its financial reporting; insurance reserve and corporate capital values are distinct from venture fund fundraising. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Debra Ann Rittenour is senior vice president, government programs at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Leads Medicare Advantage, managed Medicaid, dual special needs, long-term services and supports, and Medicare supplemental plans. The parent filing explicitly records her assumption of the Government Programs role onApril1,2025. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Heather Staples is executive vice president, enterprise business and technology solutions and operations at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Oversees planning, development and delivery of IT applications and infrastructure, technology operations and enterprise service initiatives. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Timothy Susanin is senior vice president, audit, risk and compliance at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Leads internal audit, risk assessment, controls management and compliance. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Christopher Lepre is executive vice president, commercial business at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Oversees sales and account management across medical, pharmacy, dental, vision, life, disability and stop-loss insurance markets. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Mark Barnard is former executive vice president, government programs and operations at Horizon Mutual Holdings, Inc., in a historical affiliation. The primary filing explicitly records his separation on April1,2025; his inclusion in the officer exhibit is historical and not treated as a current job. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Nicholas Peterson is executive vice president, general counsel and secretary at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Manages enterprise legal affairs and regulatory mandates, provides legal advice, and serves as secretary of the board. He certified the parent’s2025regulatoryinformation statement onMay26,2026. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Ulises Diaz is senior vice president, government and community affairs at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Leads government advocacy and community affairs and oversees the Horizon Foundation for New Jersey. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Gary St. Hilaire is chairman, president and chief executive officer at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Manages the performance and strategy of the whole mutual holding company system. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

Patrick Aylward is senior vice president, strategy, marketing and communications at Horizon Mutual Holdings, Inc., according to the dated2025parentreport. Oversees corporate strategy, marketing and communications and serves as chief of staff to the president and CEO. The primary source is the year-end2025 information statement certifiedMay26,2026; later employment changes are not inferred from older subsidiary biographies.

John Bailey advises Fiore Ventures on investments and strategy in behavioral health and related fields. His background includes domestic policy work in the White House, the US Department of Commerce, the Gates Foundation and the Chan Zuckerberg Initiative. He also advises organizations working on AI governance, education and public-interest technology. Fiore’s current public profile continues to identify him with the firm.

Judy Park is Managing Director of Investments at Fiore Ventures, confirmed by her own current promotion announcement reposted by the firm and Stanford’s current investment-committee directory. Her prior investing experience includes Owl Ventures and Bain Capital Double Impact. She studied at Harvard and Stanford’s Graduate School of Business. The firm’s current investment focus includes health care AI and family mental health; older biographies describing her as a strategic adviser are retained as historical context.

Syncona Limited is a Guernsey registered closed-ended investment company (registration55514) listed on the London Stock Exchange as SYNC. It began business as BACIT Limited on26October2012; inDecember2016 it acquired the original Wellcome-owned Syncona portfolio, changed its investment policy and adopted the Syncona name. The listed company supplies permanent capital to a life science company-building strategy, including neuroscience, retinal and central nervous system gene therapy and computational drug discovery businesses. It holds life science investments through corporate Syncona Holdings Limited and its capital pool through Syncona Investments LP Incorporated, of which it is sole limited partner. Separate English subsidiary Syncona Investment Management Limited10497864 is the regulated alternative investment fund manager and houses the manager staff; they are not represented here as listed-company employees. The listed company’s six current directors are Melanie Gee, Kemal Malik, Julie Cherrington, Norman Crighton, Gian Piero Reverberi and John Roche. Genuine historical cash capital raised was GBP206734775 at the2012IPO, GBP200M at the2013C-share listing, and GBP169581708 inDecember2016. The latter excludes portfolio assets exchanged for shares. Share prices, NAV, portfolio values and investment commitments are not treated as cash financing or external LP fund closes.

Carrie Walton Penner founded Fiore Ventures to invest in businesses and initiatives expanding mental-health access. Her background includes education research, evaluation and philanthropy. She is also a Denver Broncos co-owner and serves on the Walton Family Foundation board. Those personal and philanthropic affiliations are distinct from Fiore’s institutional investments.

Fiore Ventures is Carrie Walton Penner’s mission-oriented early-stage investment organization, founded in 2021 to improve access to affordable mental-health care for young people and families. The firm backs founders and scalable health businesses and also deploys philanthropic resources toward policy, research and the supporting innovation ecosystem. Its current investment focus spans mental and behavioral health, integrated and whole-person health, family and caregiver services, consumer wellness and health care infrastructure, with a particular interest in how AI can improve access and outcomes. Its publicly identified team includes founder Carrie Walton Penner, strategic adviser John Bailey and Managing Director of Investments Judy Park. Public company and fund partnerships are distinguished from charitable support; no external pooled-fund size or closing date has been verified. BeMe Health’s August 2024 additional-seed financing announcement explicitly names Fiore as a continuing investor. Its verified public presence is the Fiore Ventures LLC company profile; the unrelated fiore.la marketing consultancy and the parked fioreventures.com domain are excluded.

Youth digital-safety, media and education specialist, author and podcast producer. His ownOctober2025 retrospective identifies him as formerBeMe chiefyouthprivacypolicyofficer and producer ofBeingMe teenmentalhealthpodcast, with morethan25years inchildren’smedia andeducationaltechnology. His currentownsite suppliesauthenticidentity/portrait.

Healthcare commercial executive who led BeMe commercial strategy fromlate2023 through its sale toHazel. Her own published account confirms the appointment; primary partner biography names her formerBeMeCCO and describes currentSomethingsCCO service, priorPapa client-success leadership and25years inhealthcare. ExactindependentBeMe roleishistorical.

David Brillembourg Jr. is the founder of Dune Ventures. Orbit Technologies’ November2023 issuer release identifies him as the firm’s founder; his own current professional profile links dune.ventures and describes investing in exceptional people at the earliest stages. His own posts describe continued backing of Pim de Witte/General Intuition and co-leading Joon’s2023 financing. Dune Fund II’s June2026 SEC filing identifies David Brillembourg as executive officer and managing member of the GP’s GP. His professional profile lists NYU Stern education; no completed degree is inferred. He is distinct from the older hospitality entrepreneur David Brillembourg Capriles and other same-name professionals.

Dune Ventures is a US venture capital firm founded by David Brillembourg Jr. in2020, backing unconventional founders in interactive content, gaming and technology. Its current website describes a USD1–10million investment range; this is strategy guidance, not a reported individual ticket or fund size. Its published founder portfolio includes General Intuition, Orbit, Voldex, The Anti Fraud Co and Millions of Monsters. AI relevance includes General Intuition’s spatial and temporal reasoning models; neuroscience relevance includes Orbit Technologies’ immersive neurostimulation devices for virtual reality. Its official company profile identifies New York as headquarters; SEC fund filings use a Miami address. The published manager/founder sources identify David Brillembourg as founder and current investor; a complete private staff roster is not public. SEC identifies Dune Ventures Fund II, LP, a Delaware2025 venture fund, Dune Ventures GP II, LP as its general partner, and David as executive officer/managing member of the GP’s GP. The June3,2026 amendment reports USD29,732,653 subscriptions sold to21 investors, first sale June6,2025, indefinite offering. This is a subscriptions snapshot rather than a verified final close. A separately verified legal name for the management company and primary documentation for the widely reported USD100million debut-fund close were not available, so neither is asserted as a verified fund vehicle/close. This exact dune.ventures manager is distinct from French dune-ventures.com, Chinese duneventure.com, Dune Analytics, Dune Capital Management and Dune Real Estate Partners.

Founder and CEO of Behavioral Health Tech, a community and events organization connecting behavioral-health providers, payors, technology businesses and investors. Its current own speaker biography supplies her identity and portrait. BeMe’s2021issuer release includes her in its combined board/adviser list; no individual director title or current acquired-company position is inferred.

Healthcare venture investor and co-founder of Flare Capital Partners. Current Red Cell Partners biography names him senior healthcare adviser and notes continued Flare executive-partner advisory work. Previously led North Bridge’s healthcare investment practice. BeMe’s issuer named him in its combined board/adviser list in2021, without assigning an individual director seat.

Healthcare physician and entrepreneur named among BeMe’s founders in the issuer’s2021launch announcement. The same source describes prior leadership of Merit Behavioral and Alere. Founder history is recorded without inferring a current BeMe management role.

John Roche is non-executive director of listed investment company Syncona Limited. Guernsey-based chartered accountant who joined Syncona Limited’s board in October 2024. Previously a PwC partner, Guernsey managing partner and Channel Islands capital markets practice leader.

Gian Piero Reverberi is non-executive director of listed investment company Syncona Limited. Pharmaceutical commercial executive previously at Ferring through April 2026, Vanda Pharmaceuticals, Shire and Eli Lilly.

Behavioral-health entrepreneur named among BeMe’s founders in the issuer’s2021launch. Previously co-founded and led myStrength, acquired by Livongo. Current WellPower primary board directory identifies him as founder of Coella Partners; founder history is not treated as a current BeMe staff appointment.

Marketing and commercial executive who joined BeMe as chief business officer inJuly2022. The issuer biography describes prior chief marketing officer service at Twin Health and a decade at Facebook including Messenger, Messenger Kids and community operations. Her published BeMe role is historical, without an inferred current appointment.

Julie Cherrington is non-executive director of listed investment company Syncona Limited. Biotechnology executive experienced in oncology development and company leadership across North America and Australia. Trained in microbiology and immunology at Minnesota and Stanford. Julie Cherrington is venture partner - usa at Brandon Capital. Her2022 Brandon venture-partner appointment adds extensive oncology and biotechnology operating experience. Her career includes leadership at QUE, Arch, Revitope, Zenith and Pathway, with earlier research management at SUGEN and Gilead. Existing Syncona directorships and authentic portrait are preserved. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Norman Crighton is non-executive director of listed investment company Syncona Limited. Investment company specialist with experience in banking, fund management and listed-board governance. His work includes closed-ended investment companies and IPO structuring.

Kemal Malik is senior independent director of listed investment company Syncona Limited. Pharmaceutical research and development executive formerly on Bayer’s management board with responsibility for innovation and LEAPS. Joined Syncona Limited’s board in June 2020.

Melanie Gee is chair of listed investment company Syncona Limited. Investment banking adviser and listed-company director. Joined Syncona Limited’s board in June 2019; earlier worked at Lazard, SG Warburg and UBS.

Healthcare technology executive with more than30years of operating and leadership experience. Her current employer Cylinder Health named her CEO onMarch19,2026 and confirms that she previously led BeMe through its sale, after serving as Clarify Health CEO. Earlier leadership included Diameter Health, IBM Watson Health, Wellcentive, Misys and UnitedHealthcare. BeMe CEO affiliation is historical.

Clinical psychologist and Yale psychiatry faculty member focused on access, evidence-based mental-health care and digital intervention. Her current Yale biography explicitly describes her BeMe chief clinical officer service as2023–2024. She is not recorded as a current independent BeMe executive.

William Dutson is a group accountant at Syncona Investment Management Limited. Chartered accountant trained in PwC’s asset and wealth management assurance practice. Holds a Surrey economics degree.

Clinical psychologist and behavioral-health researcher, named BeMe chief clinical officer in its2021launch. Her investor biography describes youth substance-use and social-media intervention research and prior clinical leadership at Hopelab. Later BeMe sources name Amber Childs in the clinical leadership position, so Ramo’s role is historical.

Stephen Molumby is a head of portfolio management and fp&a at Syncona Investment Management Limited. CIMA-qualified finance professional previously working in financial planning and commercial finance at Wellcome and Sky. Studied business at Trinity College Dublin and Manchester.

Sarah Qian is a associate at Syncona Investment Management Limited. Endocrinologist and investor previously at ARCHIMED. Trained clinically in Melbourne and London, holds a Monash medical degree and London Business School MBA.

Sarah Crabtree is a head of legal (transactions) at Syncona Investment Management Limited. Transaction lawyer previously corporate and commercial counsel at Vue International. Earlier advised private equity clients on acquisitions and exits; studied law at Nottingham.

Child, adolescent and adult psychiatrist and digital-health medical executive. Her own website identifies her current Headway chief medical officer role. She was BeMe chief medical officer at launch and personally announced her departure inApril2023; this BeMe affiliation is historical.

Samantha Roberts is a managing director at Syncona Investment Management Limited. Clinician and healthcare leader formerly chief executive of NICE. Leads day-to-day operations at SIML as managing director under the September 2026 leadership changes and serves on Spur’s board.

Roel Bulthuis is a executive partner at Syncona Investment Management Limited. Life sciences investor with venture capital, business development and banking experience. Formerly Syncona’s managing partner and head of investments; became an executive partner under the September 2026 leadership changes.

Richard Wooster is a executive partner at Syncona Investment Management Limited. Drug discovery executive whose earlier scientific leadership roles included Translate Bio and Tarveda Therapeutics. Also serves as scientific leader and director of Slingshot Therapeutics.

Raghd Rostom is a principal at Syncona Investment Management Limited. Biopharmaceutical investor with a background in Boston Consulting Group’s healthcare practice. Has helped establish Kesmalea and Yellowstone and serves on portfolio company boards.

Pierre Joffrin is a senior associate at Syncona Investment Management Limited. Biotechnology company builder and investor previously at Jeito and OSE. Was Mogrify’s first employee and corporate development officer; studied biochemistry and pharmacology.

Nisha Sethi is a legal counsel at Syncona Investment Management Limited. Legal professional previously advising corporate service provider Animo Associates. Qualified at Noble Solicitors and studied law at Reading.

Nikki Padden is a corporate partner at Syncona Investment Management Limited. Chartered accountant with earlier operations and project roles at GlaxoSmithKline and AEA Technology. Holds a biotechnology doctorate from King’s College London and a Warwick MBA.

Nathaniel Dahan is a principal at Syncona Investment Management Limited. Biopharmaceutical investor with earlier life sciences M&A consulting experience at Deloitte. Holds a UCL biomedical engineering doctorate and conducted postdoctoral research at Imperial College.

Melina Hoffmann is a associate at Syncona Investment Management Limited. Biotechnology researcher and investor previously at BioGeneration Ventures and Valink Therapeutics. Her research experience includes Pheon Therapeutics and the Institute of Cancer Research.

Marc Perkins is a general counsel at Syncona Investment Management Limited. Corporate lawyer previously serving as general counsel and company secretary at Abcam. Earlier worked at Herbert Smith Freehills on public and private M&A.

Kenneth Galbraith is a chair of siml and executive partner at Syncona Investment Management Limited. Biotechnology executive and investor with experience as CEO, CFO, director and venture capital manager in North America. The current Syncona roster identifies him as SIML chair and executive partner.

Kate Butler is a chief financial officer at Syncona Investment Management Limited. Finance executive who joined Syncona in 2022 and became CFO in April 2024. Earlier roles included CFO of Awakn and finance leadership at Kite Europe, Gilead and Vectura.

Hitesh Thakrar is a executive partner at Syncona Investment Management Limited. Public equities and venture investor with experience managing innovation strategies at Aviva and ADIA. His interests include data science and medical diagnostics, and he has served as an Alan Turing Institute trustee. Hitesh Thakrar is publicly named by Cambridge Angels in its selected individual-member directory. Membership is an angel-network affiliation: individual investment choices are independent, and membership alone does not prove personal investment in any portfolio company.

Helen D'Silva is a executive assistant at Syncona Investment Management Limited. Executive support professional previously working at Gardiner and Theobald, the Big Lottery Fund and Land Securities.

Harriet Gower Isaac is a chief people officer at Syncona Investment Management Limited. Human resources executive with international pharmaceutical experience. Previously led European HR at Alcon and held senior HR positions at GSK and Novartis.

Watershed Ventures is a New York venture investor backing early and emerging growth companies across healthy living, productivity and purpose, and sustainable systems. Its healthcare and digital health investments include Penguin Ai’s healthcare administrative AI, mental healthcare businesses Headway and firsthand, and Maven Clinic. Its published representative portfolio also includes Tabs, Baselane, Glacier, Rivian, Warp and Yuvo. Its legal investment adviser is Watershed Collective LLC, an SEC exempt reporting adviser under CRD327754. Imraan Ahmed leads the adviser; current regulatory records also identify Samir Malik as a manager of several special-purpose vehicles. Other published partner, investor and student affiliations are qualified by source period because the public site does not provide a current comprehensive staff directory. Upsher Management’s own portfolio identifies Watershed as a2021-vintage healthcare-specialist venture fund and links directly to watershed.vc; the broader family office’s team and investments are not automatically attributed to Watershed. FundI disclosed USD24,222,500 of securities sold in November2024 within an indefinite offering, distinct from its later gross asset value and from a verified final close. The current adviser filing lists FundI and thirteen additional legal investment vehicles. This firm is distinct from climate software Watershed, Watershed Informatics, Bristol arts entities, restaurant operators and unrelated real-estate investors.

Danish Munir co-founded Watershed Ventures and was identified as an investment committee member and venture partner in primary2023 conference and event material. The current Watershed filing does not independently establish a continuing committee appointment. He is also a founding partner of GreyMatter, whose own current directory publishes his portrait. Earlier, he co-founded Genoa Telepsychiatry, formerly 1DocWay, before its acquisition by Optum, and worked at Microsoft. Founding Partner of GreyMatter Capital focused on mental and brain health. He founded Genoa Telepsychiatry, formerly1DocWay, before its acquisition by Optum, where he worked on behavioral-health network innovation. He began his career at Microsoft and studied computer information sciences at the University of Pennsylvania. GreyMatter’s published biography notes his angel-investment activity; no particular personal cash check is inferred from institutional portfolio membership.

Gwenaelle Pemberton is a executive partner at Syncona Investment Management Limited. Regulatory affairs specialist whose career includes Gilead, Pfizer, Pharmacia and AstraZeneca. Advises Syncona on regulatory strategy and investment decisions.

Imraan Ahmed leads Watershed Ventures and is the manager of its legal adviser Watershed Collective LLC, according to its March2026 SEC filing. His Kauffman Fellows biography describes earlier health-technology investing at Armory Square Ventures and Radius Ventures, as well as home-health entrepreneurship, private equity and investment banking experience. He studied finance at the University of Maryland and earned an MBA at Columbia Business School.

Momo Bi is published as a partner of Watershed Ventures by Cornell Tech’s2025 event account and her public event profile. She has participated in venture-capital and entrepreneurship programming and welcomed a Watershed summer associate in2024. Her current professional profile lists Stealth, so the later status of her operating partner affiliation is not independently established. Her public education record identifies Cornell’s graduate business program.

Mubarak Alliyu announced joining Watershed Ventures as a summer associate in2024, an appointment welcomed by partner Momo Bi. He studied at Stanford Graduate School of Business in the class of2025. His published interview describes earlier chemical-engineering studies at the University of Lagos and Imperial College London and finance, energy and risk experience. The summer appointment is qualified historically rather than asserted as current permanent employment.

Rishi Kayathi publicly announced a summer2026 affiliation with Watershed Ventures, meeting and investing in founders; his precise title is not independently disclosed. Columbia’s2025–2026 venture fellows biography identifies a UCLA neuroscience degree, prior life-sciences consulting at DeciBio and advisory work at Clear Labs, with interests in physical AI, robotics and frontier technology. Earlier mental-health app work is biographical experience, not an inferred Watershed personal investment.

Samir Malik is a Watershed venture partner in the firm’s published event account and remains a named manager of several Watershed vehicles in its March2026 SEC filing. His published healthcare biography describes founding 1DocWay, leading Genoa Telepsychiatry and later serving as CEO of firsthand, which supports people with serious mental illness. He previously worked in healthcare operations and consulting. These outside-company positions are biographical context, not additional imported current roles or personal investments. Samir Malik is publicly listed as an advisor to GreyMatter Capital. The manager’s own directory describes the professional background as: Co-founder & EVP, Genoa Telepsychiatry, Optum Behavioral Health. This directory caption describes outside affiliations and experience; it does not establish current employment at those organizations or a GreyMatter executive position.

Zain Khanna, also using Zen, interned with Watershed Ventures in2025 through Columbia’s social enterprise summer fellowship. His university account describes sourcing and screening opportunities, market research, startup due diligence and investment committee work. He is a Columbia MBA class of2026 fellow with a background in chemistry and economics. His internship and later public representation are qualified; a permanent appointment is not inferred.

Zunaira Arshad publicly represented Watershed Ventures in investment announcements and an investor networking event in2024–2025. Her own account describes work on the firm’s investments in Tabs and Penguin AI. Her current professional headline refers to building something new; no later Watershed employment or promotion is inferred. An authentic individual portrait could not be retrieved; unrelated namesakes in Pakistan were excluded.

Gonzalo Garcia is a partner at Syncona Investment Management Limited. Biopharmaceutical investor and company builder with earlier experience as a Boston Consulting Group project leader. Holds a Cambridge doctorate in protein biophysics.

Gemma Mountford is a executive assistant at Syncona Investment Management Limited. Executive support professional with earlier investment banking experience, including supporting European M&A and business services leaders at Canaccord Genuity.

Fiona Fernandez is a head of operations at Syncona Investment Management Limited. Operations professional at Syncona since 2013, overseeing technology and facilities. Previously provided executive support at AnaCap Financial Partners and studied geography and management at Leeds.

Elisa Petris is a managing partner at Syncona Investment Management Limited. Founding Syncona team member who helped establish Blue Earth Diagnostics, Quell, Beacon and Achilles. Has held operating and director roles across these life science businesses.

Technology entrepreneur and BeMe co-founder, publicly named chief technology and chief product officer at its2021launch. Previously founded family social-media product Togetherville, acquired by Disney, and worked in Facebook product leadership. Historical BeMe appointment is qualified following its2025Hazel acquisition.

Edward Hodgkin is a managing partner at Syncona Investment Management Limited. Biopharmaceutical executive and investor who helped establish Autolus and Resolution Therapeutics as their initial CEO. Earlier leadership positions included Biotica and BrainCells.

Benjamin (Ben) Vyshedskiy’s own website explicitly lists recruiting for Orbit Engineering from February through July 2026 as a past affiliation and links orbit.engineering. It describes current genetics research at Harvard Medical School, Cambridge natural-sciences studies and Bio-Squared activity beginning August 2026. His scientific publications are personal research credentials, not automatically company publications or an ongoing Orbit employee role. Month-level tenure is retained in the role text without invented exact start or end days.

Wali Qureshi’s own professional profile identifies Orbit Inc. in Boston and studies in data science and biology at Northeastern University. His public research-project description concerns perceptual learning and psychophysics analysis. Orbit’s own company directory independently names his affiliation. No executive title, clinical licence, personal investment or funding-round amount is inferred; this Boston-based researcher is distinct from same-name aerospace professionals elsewhere.

Cindy Woo is a governance and compliance assistant at Syncona Investment Management Limited. Chartered governance professional and secretary. Previously worked at Great Ormond Street Hospital Children’s Charity and in company secretarial positions in Hong Kong.

Ariana Duverge’s own public professional profile lists Orbit Inc. in Boston. She describes work at the intersection of clinical research and emerging technology and publicly recruits clinical research staff for Orbit’s Charlestown research programme. She and Steven Pang announced the Peregrine Prize for clinical-research professionals; that award initiative is distinct from Orbit company financing. The precise current internal job title and appointment day are not public in the accessible primary profile.

Clinical psychologist known as Nicki Tessler, co-founder of BeMe Health. Her primary investor biography describes more than20years of behavioral-health leadership and prior executive work at Universal Health Services. She stepped down as BeMe CEO inJune2025; founder status does not imply current operating management.

Spencer Green’s own public professional profile lists Orbit Inc. in Boston and Massachusetts Institute of Technology studies on leave. A first-hand April 2025 Orbit interview names him among the team members who joined the company after it moved to Boston. The Eigenprize’s own programme page also names Green as an organizer. No specific executive title, equity ownership or programme co-funder identity is inferred from these affiliations.

Tina Chou, PhD, is a clinical psychologist and psychiatric-neuroscience researcher named in Orbit’s own public affiliation directory. Her own professional profile describes expertise in clinical psychology and neuroscience. Her published author biography identifies a Harvard clinical-psychology doctorate and Brown clinical internship, with research using neuroimaging and brain stimulation. Orbit does not publish a precise current title on its public directory, so this record does not infer employment status, an executive appointment or a medical degree.

Christina Seed is a group reporting and treasury manager at Syncona Investment Management Limited. Chartered accountant overseeing financial reporting and treasury. Trained at Deloitte in investment funds and joined Syncona in 2020; holds a Warwick biomedical sciences degree.

Chris Hollowood is a chief executive officer and chief investment officer at Syncona Investment Management Limited. Life science investor at Syncona since its 2012 launch. His work includes building gene therapy companies addressing eye, liver, kidney and central nervous system diseases.

Colton El-Habr co-founded Orbit Technologies with Steven Pang in February 2023. Its November 2023 issuer release identifies him as CTO. A first-hand April 2025 interview describes his transfer from Georgetown to Johns Hopkins engineering and departure in 2023 to build Orbit full-time. His public professional profile continues to identify Orbit; the precise current executive title is not independently republished. The Thiel Foundation named him a 2025 fellow alongside Pang.

Mark Khrapko’s own website identifies his work as neurotechnology at Orbit, links the exact orbit.engineering domain and publishes his company email. A first-hand April 2025 interview names him as a member of the Orbit team. His own site shows hands-on electrode, EEG and prototype engineering work. He is also named as an Eigenprize programme organizer; this outward programme role is separate from raising cash for Orbit. No unverified executive title or appointment day is inferred.

Steven Pang co-founded Orbit Technologies in February 2023 with Colton El-Habr. The company’s November 2023 issuer release names him co-founder and CEO. He was a Georgetown student when developing the non-invasive vestibular-neurostimulation venture, and the Thiel Foundation named him a 2025 fellow. His public professional profile and the current company directory retain the Orbit affiliation. Founder fellowship support is distinct from company equity financing.

Caroline Horsford is a executive assistant at Syncona Investment Management Limited. Provides executive support to the board and investor relations team. Previously supported marketing and research leadership at Odgers Berndtson; studied Hispanic studies and history at Nottingham.

Orbit Technologies is the Boston-area neurotechnology company operating at orbit.engineering, whose research-participant website identifies the legal entity as Orbit Technologies, Inc. It also uses the Orbit Inc. and Orbit Technology brands. Steven Pang and Colton El-Habr founded the business in February 2023. Early work used ear-worn electrical vestibular stimulation to evoke movement sensations for games and virtual reality; these prototype descriptions and founder claims do not establish independent clinical efficacy. Its current company site presents a broader neuroscience mission, while its own research website describes non-invasive physiological studies using skin sensors and electrodes to measure heart rate, breathing and balance in adult volunteers. The participant website identifies independent WCG IRB review, explicitly distinguishes research from medical treatment, and says the investigational study device is not FDA approved. The current public team affiliations include founders Pang and El-Habr, neurotechnology contributor Mark Khrapko, Spencer Green, clinical-research and operations contributor Ariana Duverge, Wali Qureshi, and psychologist Tina Chou. Precise titles and employment status are qualified where the primary directory does not disclose them; Benjamin Vyshedskiy’s February–July 2026 recruiting role is historical. Orbit announced an oversubscribed USD500,000 pre-seed from Dune Ventures on 7 November 2023. University sources separately document a USD30,000 Bark Tank prize on 26 October 2023, a USD12,000 Johns Hopkins Fuel grand prize announced 21 December 2023 and the cohort’s USD5,000 stipend; these are awards rather than venture-equity checks. AGI House Ventures’ own investment portfolio explicitly links the exact orbit.engineering domain and classifies it as neuroscience, but does not disclose that manager’s financing date, stage, ticket or legal fund vehicle. The founders’ 2025 Thiel fellowships and Orbit-associated outward grant programmes are not company equity rounds. Later secondary fundraising and valuation claims lack sufficient primary corroboration and are not entered as priced financing. The company is distinct from the older developer-community SaaS Orbit with 2020 and 2021 Martin Casado financing records, from legacy Orbit semiconductor issuers, and from orbital-space or aerospace companies.

Annabel Clark is a head of corporate affairs at Syncona Investment Management Limited. Corporate communications specialist previously advising investment and corporate clients at Greenbrook Communications. Studied history at Bristol.

Anastasia Prechistenskaya is a people partner at Syncona Investment Management Limited. Human resources professional whose earlier roles included Alcon, Diageo, Groupe SEB and Sanofi, with regional responsibilities in Russia, Europe and the UK.

Horizon Mutual Holdings, Inc. is the New Jersey nonprofit mutual holding company and ultimate parent of the Horizon health insurance and diversified-services group. The parent was formed on November1,2022 following state approval of the reorganization; its subsidiary Horizon Healthcare Services, Inc., operating as Horizon Blue Cross Blue Shield of New Jersey, remains a separate legal stock insurer. Its statutory mission combines affordable and accessible health insurance, integrated care, and innovation and diversified services for members. The group reported about3.45million members at year-end2025. The parent makes strategic healthcare technology investments: Penguin Ai names the exact parent as a participant in its September11,2025 USD25million SeriesA; CredibleMind names it the lead investor in its October29,2024 USD7.5million SeriesA; Solera Health names it in its January14,2025 USD40million SeriesE. These investments concern healthcare administration AI, personalized mental wellbeing and digital health integration. This profile represents the exact nonprofit corporate investor, not a conventional LP venture fund or the distinct Horizon Healthcare Services legacy investor record. The shared Horizon group insurance branding is used with its scope disclosed; a separately published parent-only logo was not identified. The latest available primary year-end2025 information statement, certified May26,2026, identifies Gary D. St. Hilaire as chairman, president and CEO, twelve named officer records including one explicitly departed executive, a twenty-member board and five additional senior managers. Historical officer titles and subsidiary careers are qualified against that dated parent filing. Insurance premiums, reserves, investment assets, debt securities and approved internal capital-transfer limits are not LP fund closes or undisclosed venture capital allocations.

Alessio D'addabbo is a analyst at Syncona Investment Management Limited. Biological scientist with a Southampton PhD studying HIV vaccine design using biophysics and glycobiology. Previously interned at Syncona and Resolution Therapeutics.

Syncona is a UK-based life science investment and company-building group founded by Wellcome in 2012. This profile represents the Syncona investment brand, distinguishing its Guernsey listed investment company Syncona Limited (registration 55514, formerly BACIT Limited, LSE: SYNC) from subsidiary Syncona Investment Management Limited (English company 10497864), its regulated alternative investment fund manager. The listed vehicle began business and trading on 26 October 2012; its 2016 transition acquired the original Syncona portfolio and adopted the Syncona name. Syncona funds and helps build biotechnology businesses, including gene and cell therapies, small-molecule drug discovery, neurological disease programmes and computational oncology. Current portfolio examples include Spur’s Parkinson’s disease gene therapy work, Beacon’s retinal gene therapies, Mosaic’s computational drug combinations and OMass’s molecular discovery platform. The September 2026 leadership changes made Chris Hollowood CEO and CIO, Samantha Roberts managing director, and Roel Bulthuis an executive partner. The separate listed-company board is chaired by Melanie Gee. Investments are held through corporate Syncona Holdings Limited; the capital pool is held in Syncona Investments LP Incorporated, whose sole limited partner is Syncona Limited. Permanent listed equity, sole-LP capital-pool assets and company investment commitments are distinguished from external multi-investor LP fund closes. Wellcome’s historical investment does not make it the buyer of every Syncona portfolio company.

Head of Healthworx Accelerator, as identified in the platform’s August 2025 interview. Her background includes policy work on U.S.–East Asia relations, founding an education technology startup in Beijing, and the Aspen Institute’s Global Leaders Network. She joined the predecessor 1501 Health program in 2022 and supports early healthcare companies with commercial relationships and ecosystem access.

BeMe Health, Inc. is a digital behavioral-health company established in 2021 to support adolescents through mobile emotional-wellbeing content, mood tracking, coaching, and access to clinical and crisis support. It was acquired by Hazel Health in 2025 and its former domains now redirect to Hazel. Hazel describes BeMe as its Tier1 and subclinical wellbeing offering for students, including on-demand chat coaching and safe virtual spaces. Its 2021 launch announcement proposed artificial intelligence and natural-language processing for personalization; that plan is not treated as independently verified current AI deployment or clinical performance. Public leadership records below are qualified by their publication period: founder Nicki Tessler left the CEO position in June 2025, successor Terry Boch led the sale and departed before joining Cylinder Health as CEO in March 2026. No separate current BeMe executive directory is published. The company is distinct from Casey Neistat’s 2015 Beme media startup and from the autism software company BeMe.ai. Verified financings includeUSD7M seed in 2021, CHCF’s USD1.45M program-related investment in 2022, and USD12.5M additional seed capital in 2024; acquisition price is undisclosed. Its own2021founders article publishes individual director and advisor titles, recorded with historical qualifications.

Allison Hydzik serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Angélica Herrera serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Anna Mamo serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

April Hopper serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Ashleigh Ketter serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Brent Burns serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Brian Susko serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Carly Cook serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Chris Waters serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Craig Ball serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Curtis Stratman serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Dan Tarpey serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

David Gibson serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

David Okonkwo serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation. David is a University of Pittsburgh neurological-surgery professor who joined Enterprises in 2018 to focus on medical technology and neuroscience. He helps develop partnerships through UPMC’s Health Technology Advancement Program. He earned an MD and PhD at Virginia Commonwealth University and trained in neurosurgery at the University of Virginia.

Deepan Kamaraj serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Don DeCorte serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Eliza Swann serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Fabian Tenenbaum serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation. Fabian leads the division’s venture strategy, corporate capital deployment and formation of companies across therapeutics, digital health and translational science. His prior executive experience includes Nectin Therapeutics and Bellerophon Therapeutics. His current biography describes responsibility for the corporate evergreen investment platform.

Hank Safferstein serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation. Hank combines scientific, legal and business training, including a doctorate in neurobiology. His current Enterprises biography identifies him as Generian Pharmaceuticals CEO and a former founding CEO of Cognition Therapeutics, where he helped advance Alzheimer’s research into clinical development. Earlier roles included biotechnology business development and NIH technology transfer.

James Bauersmith serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Jeanne Cunicelli serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation. A life-sciences venture investor formerly at Bay City Capital, Jeanne joined UPMC in 2017 and became Enterprises president in January 2021. She oversees the division’s translational-science and digital-health investment and company-building activities. Her education includes cognitive psychology at Carnegie Mellon and an MBA from the University of San Francisco.

Jeffrey Jones serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

John Lowman serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

José-Alain Sahel serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation. José-Alain is a clinician-scientist studying retinal degeneration and restoration of sight through approaches including gene therapy, optogenetics and artificial retinas. He chairs ophthalmology at the University of Pittsburgh and founded the UPMC Vision Institute in 2023. His Enterprises role connects ophthalmic research and clinical expertise to commercialization.

Julia Bennett serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Julian Hassinger serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Kathryn Heffernan serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Kathy Griffin serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Kelsey Holden serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Ken Howard serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Ketki Karanam serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Kritika Verma serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Margaret Steere serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Maryam Jalal serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Matthew Grant serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Matthew Junker serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Matthias Kleinz serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Michele Mueser serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Nick Shapiro serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation. Nicholas (Nick) Shapiro joined BrainCheck’s board in March2024 representing UPMC Enterprises. UPMC’s own biography confirms the Nick/Nicholas naming identity.

Nicole Ansani serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Parker Cahn serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Philip Jones serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation. Philip focuses on selecting and translating scientific discoveries into potential medicines. His background includes drug discovery at Merck and establishment of drug-discovery teams at MD Anderson. His current Enterprises role covers science and discovery investment and development, with experience moving research programs into clinical trials.

Randall Dye serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Rosheema Bala serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Sara Fest serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Soun Khountham serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Stuart Ingram serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Tyler Crawford serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Valerie Harrison serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Alexander J. Anetakis serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Andrew Adrian-Karlin serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation.

Alan Ashworth is a scientific adviser at Overwater Ventures. His cancer-research career includes discovering BRCA2 and work on synthetic lethality underlying PARP-inhibitor treatment approaches. Overwater’s biography describes UCSF cancer-center leadership and scientific co-founding of Tango Therapeutics; these outside affiliations remain source-qualified.

Carolyn Coles-Devine leads platform and operations at Overwater Ventures, supporting firm infrastructure and portfolio-company commercialization. Her prior operating career includes leadership at lululemon, Canada Goose and Northern Reflections. She focuses on teams, founder relationships and practical growth support.

Ivy Ross is a venture partner at Overwater Ventures. Her design career includes Google consumer-device hardware and senior roles across major consumer brands. She co-authored Your Brain on Art, exploring connections between creativity and neuroscience. Outside-employer titles reproduced in Overwater’s biography are historical context unless separately confirmed current.

Kristina Simmons is the founder and managing partner of Overwater Ventures. She previously worked in market development at Andreessen Horowitz and as a chief of staff and investment partner at Khosla Ventures. Earlier, she helped build lululemon’s digital channels and emerging-products initiatives. She leads Overwater’s early-stage investment and founder-support strategy.

Maria Molland is an adviser at Overwater Ventures and an investor, operator and board director. She previously led Thinx as CEO through its acquisition by Kimberly-Clark in 2022. Her career includes executive roles at eBay, Yahoo, Thomson Reuters, Dow Jones, Fab.com and Disney.

Overwater Ventures is an early-stage venture capital firm founded and led by Kristina Simmons, backing companies in human and planetary health. Its investment themes include healthcare, biology, artificial intelligence, robotics, climate technology and food innovation. The firm combines investing with practical commercialization, market-development and operating support. Its current public portfolio includes Penguin Ai’s healthcare language models, Overstory’s AI vegetation analysis, Adaptyx’s biosensor platform and medical and biotechnology businesses. Its neuroscience connection includes science adviser Alan Mardinly’s work on optogenetics and neural interfaces and venture partner Ivy Ross’s research on art and the brain; these professional affiliations are distinguished from undisclosed portfolio investments in their employers. The legal adviser is Overwater Ventures LLC, CRD317227, with founder Kristina Simmons as controlling managing member. Its March2026 filing identifies FundI, FundII and three separate special-purpose vehicles. The debut fund completed a USD20 million close announced in April2023. Later regulatory gross asset values and a USD50 million FundII offering target are not treated as new money raised. Seven named current investment, operations and advisory professionals appear in its own directory.

A.G. Breitenstein is a healthcare advisor to Define Ventures. Its biography identifies her as founder and executive chair of FOLX Health, a healthcare platform serving LGBTQIA+ communities. She previously co-founded Optum Ventures and Humedica and held product leadership roles at Optum Analytics. Her education includes public health, law and undergraduate study at Harvard, the University of Connecticut and Yale.

Amanda Duckworth is a communications advisor to Define Ventures. Her work covers reputation management, marketing and crisis communications. Earlier leadership roles included Kleiner Perkins and Brunswick Group, alongside communications work for investment banks and a law firm. Her published biography describes legal education in the United Kingdom.

Ashley Yuki Alexander, also named Ashley Alexander in her biography, is listed by Define Ventures as a former consumer advisor. Its updated biography identifies her as vice president of product for healthcare at OpenAI and describes earlier product leadership at Instagram. She studied engineering, computer science and business at the University of Pennsylvania and Wharton. Her Define affiliation is explicitly historical, with appointment and departure dates unpublished.

Bangaly Kaba is a consumer advisor to Define Ventures. Its biography describes product-management leadership at YouTube, earlier work at Reforge, Instacart, Instagram and Facebook, and experience advising consumer-technology companies. His advisory role does not imply a personal investment in any portfolio company.

Beth Bierbower, also named Elizabeth Bierbower in her biography, is a healthcare advisor to Define Ventures. Her experience spans health-insurance leadership, managed care and digital-health partnerships, including senior leadership at Humana. Her published biography also describes board work with healthcare services and technology companies.

Carolyn Magill is a venture partner at Define Ventures. Her published experience includes leading Aetion and Remedy Partners, payer strategy and operations at Evolent Health, and operational leadership at UnitedHealth Group. She studied at Wharton and Harvard. Healthcare operating executive and former Aetion CEO. Her primary investor biography describes prior leadership across value-based healthcare organizations. Aetion’s own September2024announcement confirms her transition from CEO to senior adviser. BeMe named her in its combined board/adviser group in2021; no individual director title or current acquired-company appointment is inferred.

Chirag Shah is a partner at Define Ventures. His healthcare investing and operating background includes The Carlyle Group, Imagine Health and Castlight Health, with work spanning strategy, analytics and product development. Earlier he worked in investment banking at Morgan Stanley and studied finance and pre-med at New York University.

Chuka Esiobu is a principal at Define Ventures. His earlier roles included healthcare venture investing at Bessemer Venture Partners, clinical innovation and strategy at Evolent Health and consulting at Boston Consulting Group. He studied neurobiology at Harvard, conducted thesis research at the Harvard Stem Cell Institute and earned an MBA at Wharton.

Debby Meredith is a technology advisor to Define Ventures. She has worked with engineering and product teams, including founder support and venture operating roles at Mohr Davidow Ventures. Earlier positions included Netscape, Collabra Software, Slate Corporation and other technology businesses. She studied computer science at Stanford and computer science and mathematics at the University of Michigan.

Erin Hardy is accounting and operations manager at Define Ventures. Her prior experience includes client relationship management at Mariner Wealth Advisors and fund accounting and administration at Aduro Advisors. Her published education includes accounting and finance at Chapman University.

Garrett Howard is a principal at Define Ventures. His background includes healthcare company building and buyouts at Rubicon Founders, venture and growth investing at Longitude Capital, healthcare investment banking at Lazard and finance work at Pantheryx. He studied at Wharton and the University of Colorado.

Hong Truong is a principal at Define Ventures. Her published experience includes healthcare impact investing at the California Health Care Foundation, health-system venture investing at Cedars-Sinai and MemorialCare, Kaiser Permanente Ventures and health-economics consulting at Analysis Group. She studied public health at Yale and human biology and international relations at Brown.

Jia Li is an AI advisor to Define Ventures. Its published biography identifies her as co-founder, president and chief AI officer of LiveX AI and describes earlier AI research leadership at Google Cloud and Snap. She earned a computer-science PhD at Stanford and has worked on AI applications in medicine and public-interest settings.

Jim Pursley is a commercial advisor to Define Ventures. Its biography identifies him as president of Hinge Health and describes earlier commercial leadership at Livongo, Care Innovations and GE Healthcare. He studied management science and information systems at Penn State and earned an MBA at Northwestern’s Kellogg School.

Karsten Vagner leads people operations at Define Ventures. He previously held people leadership roles at Maven Clinic, Hired, AppNexus and Zocdoc, supporting recruiting, organizational growth and company leadership.

Katharine Morris is administrative assistant and office manager at Define Ventures. She previously worked in development at the San Francisco Zoological Society and guest services at the Commonwealth Club. She studied philosophy and religious studies at the University of San Francisco.

Lauren O’Mahony leads marketing at Define Ventures. Her earlier experience includes senior marketing and communications leadership at Carta, fractional communications leadership at Digit, public relations at Mighty Public Relations and Eventbrite. She supports how the venture firm and its founders communicate their work.

Lynne Chou O’Keefe founded Define Ventures and is its managing partner. Her earlier career included healthcare venture investing at Kleiner Perkins, commercial and product leadership at Abbott Vascular and Guidant, enterprise-software investing at Apax Partners and investment banking at Goldman Sachs. Her published education includes Harvard Business School and industrial engineering at Stanford.

Michael Wert is a partner at Define Ventures. He previously invested in healthcare technology and services at Longitude Capital and worked in healthcare investing at Warburg Pincus, consulting at McKinsey and investment banking at Merrill Lynch. His education includes Stanford Graduate School of Business and Whitman College.

Peter Fine is a healthcare advisor to Define Ventures. He led Banner Health from 2000 until June2024, following leadership roles at Aurora Health Care and other hospital organizations. His biography describes healthcare-administration education at George Washington University and undergraduate study at Ohio University. The historical CEO role is not presented as a current executive appointment.

Earlier source-recorded professional biography (outside roles may have changed; source provenance retained): Seth Cohen is a commercial advisor to Define Ventures. Its biography identifies him as president and a director of Cedar and previously CEO and co-founder of OODA Health, which Cedar acquired in 2021. His earlier experience includes Castlight Health and McKinsey, with graduate study at Harvard and undergraduate study at Stanford. Insight Partners source, reviewed October 8, 2026: As P&G’s Chief Information Officer, Seth Cohen is responsible for elevating the company’s digital transformation strategy to improve the consumer experience and deliver business growth. Cohen brings unique perspective on how to leverage cutting-edge technologies to transform the retail space and advance internal processes. He has a proven track record for building world-class IT functions and developing top talent to become future industry leaders. Cohen has spent over 30 years working in consumer goods and retail industries. Most recently, he led PepsiCo’s IT function in delivering capabilities across all aspects of the value chain. Prior to his tenure at PepsiCo, Cohen was global CIO for Reckitt Benckiser Group, (RB) responsible for leading the company’s IT transformation including major systems deployments, upgrades and integrations. Cohen and his wife of 21 years have four children and reside in Dallas Texas, with plans to relocate to Cincinnati, OH in 2025.

Shannon Knous is vice president of finance and operations at Define Ventures. Her earlier experience includes fund administration and controller work at Aduro Advisors and public accounting at BDO USA. Her published biography identifies her as a Colorado licensed certified public accountant and a UCLA economics graduate.

Define Ventures is a San Francisco venture capital firm focused on early-stage healthcare technology, including AI-enabled clinical and administrative tools, digital health, care delivery and patient engagement. Founded and led by Lynne Chou O’Keefe, it combines venture investing with healthcare operating experience and a published network of commercial, clinical, AI, technology and communications advisers. The legal adviser is Define Ventures Management, LLC, CRD299671, which reports to the SEC as an exempt reporting adviser (file802-114577), rather than an SEC-registered investment adviser. Its March2026 FormADV identifies six private fund vehicles. The firm’s website describes USD800M in assets under management, which is not a new closed fund. Its April18,2023 announcement reports USD460M raised across FundIII and an Opportunities fund combined; no individual fund split is inferred. Its portfolio includes healthcare AI companies and Readily, which names Define among its backers. This US healthcare investor is distinct from the Canadian DefinedVC firm.

SUTD Venture Innovation Fund is the Singapore University of Technology and Design’s institutional co-investment program, launched in 2022 according to its annual report. It operates through the university’s Venture and Incubation Experience ecosystem, formerly called Venture, Innovation and Entrepreneurship. The program co-invests in pre-seed and seed-stage ventures connected to SUTD students, alumni, researchers, faculty or entrepreneurship-program participants, with other investors expected to lead their fundraising rounds. It also provides fundraising guidance, investor introductions and incubation support. Its current investment portfolio lists seventeen companies, including healthcare AI company Readily, AI and data companies BetterData, Datature, Pints.AI and Staple AI, quantum-software developer Entropica Labs, post-quantum security company pQCee and robotics ventures. Readily is linked by the university to readily.co, which redirects to its current readily.ai identity; the portfolio establishes institutional backing without disclosing an exact financing date, stage or ticket. This profile represents the named university investment program, not a separately verified incorporated fund manager or independent limited partnership. The legal parent SUTD is a Singapore company limited by guarantee incorporated July 24, 2009, with public-character charity status described in its 2024/25 annual report. The authentic SUTD university logo shown on the program page is used with explicit parent-brand scope; no standalone VIF logo is claimed. Publicly named VIE affiliations include Celestine Khoo as Senior Director in the office’s own January 2026 award announcement and Weiren Loh as a program staff member, whose exact Program Manager title is directly confirmed in a historical delivery-partner case study. These are program-office affiliations, not inferred dedicated VIF investment-committee appointments or personal investment checks. A complete current VIF decision-making roster is not publicly published. Program capital allocation and actual fund closing size/date are undisclosed; broader university grants, DIVE initiative budgets, university endowment assets and separate Create4Good awards are not treated as VIF LP capital or fundraising.

Celestine Khoo Geok Choo is publicly identified by SUTD’s Venture and Incubation Experience office as its Senior Director in a January 2026 award announcement. Her current Far East Hospitality Trust biography describes senior innovation and enterprise leadership at SUTD, following investment-banking experience at DBS and UBS, capital-market and reserve-management roles at the Monetary Authority of Singapore and Asia leadership at Principal Financial Group. These career affiliations are context, not inferred simultaneous employment. Her role is a university venture-office affiliation; no personal Readily cash check or dedicated VIF committee appointment is implied. The matching authentic portrait is a historical photograph published with a named February 2016 appointment report, not represented as a newly taken image.

Weiren Loh is publicly associated with SUTD’s venture and incubation programs. A direct delivery-partner case study identifies him as SUTD Program Manager in the 2022 Create4Good engagement, and his own public posts describe organizing the university venture ecosystem. His earlier NUS biography identifies him as an NUS Overseas Colleges program manager. A newer Associate Program Director title appears in aggregators but has not been independently verified from a current primary roster and is not imported as confirmed. An authentic matching portrait was not retrievable from the primary NUS page, so no substitute photo is used. A dedicated Venture Innovation Fund investment-decision role or personal investment check is not inferred.

John Santelli is the Chief Executive Officer of Solera Health, as confirmed by its current official leadership page. Penguin Ai expressly names the former UnitedHealthcare chief information officer as an individual angel investor in its2024 seed financing. This personal investment is distinct from any UnitedHealth Group, Optum or institutional-fund holding, and he is distinct from the Columbia physician with the same name.

Peter Longo is Chief Executive Officer of Spectator Health, whose own biography identifies his previous Chief Revenue Officer position at Penguin Ai. Penguin’s September2025 announcement named him as a founding-team member and described earlier healthcare commercial roles at McKesson, Blue Spark Technologies, Sunquest and Sirono. Penguin subsequently appointed Nate Kiely as CRO in May2026; Peter’s exact departure day remains undisclosed.

RAAPID commercial leader identified as vice president of sales in the company’s own March 2026 RISE National leadership listing. The issuer publishes an original named portrait; further professional background and tenure dates remain undisclosed.

Sales leader named by RAAPID in its March 2026 RISE National leadership listing as a vice president of sales. The issuer publishes his portrait and exact professional name. Further biographical details and appointment dates have not been independently established.

Marketing director for RAAPID identified as its named press contact in the company’s April 9, 2026 financing release. A genuine named portrait and broader professional biography were not located in the accessible primary sources.

Risk-adjustment consultant listed by RAAPID among its public March 2026 event leadership participants. The company provides an original named portrait. The consultant affiliation is recorded separately from an executive or general employee appointment.

Commercial leader published by RAAPID as a vice president of sales in its March 2026 RISE National leadership listing. The issuer provides a named original portrait. This record reflects the latest verified issuer-published title and does not infer an employment start date or later promotion.

RAAPID, Inc. develops healthcare AI software for medical coding and risk adjustment. Its platform combines neural models with medical knowledge graphs and clinical rules to interpret unstructured records, identify diagnoses and support traceable coding decisions for health plans, accountable-care organizations and providers. It addresses retrospective chart review, prospective care gaps and audit workflows across value-based care programs. The company is headquartered in Louisville, Kentucky and publishes founders Chetan Parikh and Vatsal Ghiya plus additional commercial and consulting leaders. Primary releases document M12 Series A financing in January 2025, an additional UPMC Enterprises Series A investment in March 2026, and a strategic Healthworx tranche in April 2026; individual and aggregate financing amounts are undisclosed. Neuro-symbolic AI describes its software architecture and does not establish a neuroscience therapeutic business. Earlier clinical-data and transcription milestones precede the founders’ stated 2022 RAAPID launch; corporate legal formation date remains unverified.

Healthcare entrepreneur and founder and chief executive of RAAPID. The company’s own biography describes more than twenty years building healthcare technology and a 2022 launch focused on clinically defensible risk adjustment. He leads the company’s neuro-symbolic AI platform.

Co-founder and CMO of RAAPID, as styled in its current official leadership directory. His published background includes more than twenty years in healthcare software and services and co-founding a medical-transcription business whose clinical-data expertise informed RAAPID. The company does not expand the CMO abbreviation in this directory.

Adi is Team8’s HR & Talent Acquisition Specialist. Her mission is to hire the best talents to create and build Team8’s new cybersecurity, data, and fintech companies. Formerly Talent Acquisition Specialist at Innovid and Recruitment Team Leader at See.V. Adi holds a B.A degree in Management & Human Resources and an M.B.A specialized in Organizational Behavior & Development.

I worked as a personal assistant to the CEO at Flying Tiger Copenhagen for three years. I’m currently based in Rishon LeZion. I love traveling, exploring new places, and reading. I’m a good listener and always happy to help those in need.

Before joining Team8, Michael spent 37 years serving in the US Navy, where he rose to the rank of four-star admiral. He held positions focused on cyber, intelligence, maritime operations, and maritime security, culminating in a four-year tour as commander of the US Cyber Command and Director of the NSA. His extensive service included duty with the Chairman of the Joint Chiefs of Staff, the Joint Chiefs of Staff, and US Indo-Pacific Command. He commanded at the unit, fleet, and service component levels in the Navy.

He has more than two decades of experience, and is passionate about leveraging performance marketing, data, and technology to drive sustainable company growth. His expertise lies in disruptive growth hacking, software architecture, AI analysis, and big data.

He brings extensive strategic and business expertise from his two years as a senior strategy consultant at Strategy& by PwC, leading projects for private and public sectors and advising C-level executives.

Before joining Team8, Amir held positions in companies such as AiVF,AI solution for IVF where he was Chief Commercial Officer, and Inspire, one of the largest patient-focused social networks) where he was a Co-founder.

Amir managed a team of high-level researchers and developers in an elite IDF cyber unit. He holds more than 10 patents, most of which are for cybersecurity products.

Amit holds a bachelor’s degree in law from The College of Management Academic Studies and completed her internship in commercial and civil litigation at Arnon, Tadmor-Levy.

At Team8, Asaf leads global marketing and positioning across the fund and its portfolio companies. Working within Team8’s unique model, which combines an in-house company-building team with a global network of C-level executives known as the “Village,” he partners with founders from inception to launch and growth – shaping strategy, narrative, product marketing, go-to-market architecture, and brand design to transform disruptive ideas into market leaders.

Most recently, Asaf led the onboarding of financial partners at Pagaya, a leading fintech company providing AI-powered credit analysis capabilities. In this position, Asaf worked with banks, fintech, lenders, and credit card issuers to help them grow their business by connecting to Pagaya’s network and utilizing its credit analysis technology. Before Pagaya, he held multiple roles at Via, the TransitTech startup, where he worked with cities, governments, and private corporations to launch and scale technology-enabled smart transportation services globally.

With more than 25 years of experience in cybersecurity and technology, he formerly served as Team8’s CTO. He now uses his extensive experience and access to talent to play a critical role in ensuring the success of our founding teams and startups, and has so far established and scaled over a dozen companies.

Over the past several years, Assaf has built partnerships across Israel’s global tech and innovation ecosystem, most recently as Head of Partnerships at Tech1 Conference, and previously at Future Summit and EcoMotion. Earlier in his career, he worked at Israel’s Ministry of Foreign Affairs, including a posting at Israel’s Mission to the United Nations in New York.

Aviv has extensive experience in digital marketing and will help our companies with growth efforts. On the group level, Aviv will lead our marketing operations, digital assets, and also strategic partnerships.

Aviv is Team8’s VP of HR. Her mission is to hire the best talents to create and build Team8’s new Cybersecurity, Data Science, Fintech, and Digital health companies. Aviv has vast experience in HR & Talent Acquisition in the Hi-tech industry. Aviv holds a B.A degree in Management & Human Resources and an M.B.A from Ben-Gurion University.

Before joining Team8, Ayala spent three years at Payoneer. Her most recent role was Strategy & Operations Manager in the Chief of Staff Office, where she led global cross-functional strategic initiatives and high-impact projects. Before that, Ayala served as a Business Operations Process Manager, driving scalable process design, operational efficiency, and customer-journey improvements for high-value clients.

Bar brings a unique blend of community leadership, strategic partnerships, and business development to Team8. He is responsible for leading the firm’s industry relations, building and managing strategic partnerships, and expanding Team8’s global community of entrepreneurs, executives, and ecosystem leaders.

Before joining Team8, Carin spent 4 years as a Manager at PwC Israel, in the Management Consulting team, specializing mostly in IPO readiness and general support as well as scale up & innovation, with extensive project and change management experience.

Before joining Team8, Chen worked in various financial positions in a Private Equity fund. Prior to that, Chen was a manager in the audit department at Ernst & Young, specializing in VC clients.

The Team8 advisor directory lists Christopher Ott MD, FACEP with the external professional title Former CMO Physician Services. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

Before joining Team8, Daniel led Israeli venture strategy for the George Kaiser Family Foundation (GKFF), where she built and managed the foundation’s dedicated investment activity in Israel across sectors including cybersecurity, AI, and digital health. In that role, she sourced and led investments in companies such as Guardz, Gem Security (acquired by Wiz Security), and Sensi.AI, while cultivating deep partnerships with founders, funds, and corporate stakeholders.

Before joining Team8, Dekel worked for five years as a Controller at Zerto. Prior to that, she completed her internship at Ernst & Young in the High-Tech department.

Demetrios previously served as Chief Executive of the Medicare program at the Centers for Medicare & Medicaid Services. He was a Senior Executive for Medicare at UnitedHealthcare, and served as Deputy General Counsel and then Associate Deputy Secretary at the US Department of Health and Human Services where he played a leading role across the department’s agency portfolio, including the Food and Drug Administration, Office for Civil Rights, and Office of the National Coordinator for Health Information Technology. He also built practices at two leading healthcare law firms.

The Team8 advisor directory lists Dr. Sachin Jain with the external professional title President and CEO. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

The Team8 advisor directory lists Dr. Shlomit Wagman with the external professional title Chief Compliance Officer. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

He has over 15 years of experience in cybersecurity and applied data science, and has worked closely with public and private sector leaders to solve security and data challenges.

She also served in Israel’s elite 8200 unit and later continued with permanent service in the Israeli Air Force, building strong operational skills and a can-do mindset.

Eviatar is an IT Manager in the Team8 IT department. Prior to joining Team8, Eviatar worked as a system admin for over 10 years at cybersecurity companies, including at Insights and Madsec. Eviatar was a medic and fighter in the Israeli Artillery Corps. He holds both MCSA & CCNA certifications.

Eyal is a Data Scientist and product leader with over 15 years of experience. He is co-founder and CTO of Zone7 Technologies (acquired by SVEXA), a pioneering AI platform optimizing the performance and longevity of world-class athletes. At Zone7, he developed AI-based injury risk forecasting from concept to a premium product used by elite organizations across the NBA, NFL, EPL, and beyond, overseeing all R&D, product, and CS operations.

Gal began her career at the U.S. Embassy, where she spent three years working in the Security Division, including at the Ambassador’s Residence. Most recently, she worked at Pagaya as an Executive Assistant to two VPs in different departments. She is currently studying Political Science and International Relations at the Open University.

She supports founders with the ideation, building, and scaling of their businesses. As well as financial expertise, Galia has experience with B2B sales methodologies and intrapreneurship.

At Team8, Gilad works with our portfolio companies on the part that usually takes founders the longest: getting in front of the right enterprise buyer. Design partners, first customers, the CTO who has the exact problem you solve. I run the intro, prep both sides, and stay involved until something real happens.

As the Security & IT Tech Lead at Team8, Guy Elias is the leader for the organization’s Security and IT functions. His responsibilities encompass overseeing cloud security, managing enterprise infrastructure, and handling all day-to-day technology operations.

The Team8 advisor directory lists Harit Talwar with the external professional title Board Member. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

Prior to joining Team8 Capital, she worked as an Office Manager and Personal Assistant to the Managing Director at Houlihan Lokey, an investment bank. Before that, Hilla spent three years in Rome, Italy, and two years in Manila, Philippines, working for the Israeli Embassy while indulging her love of scuba diving and exploring Asian cuisine.

The Team8 advisor directory lists Ido Gileadi with the external professional title Executive Advisor. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

Ilya is a seasoned technology leader with extensive experience in artificial intelligence, cybersecurity, and cloud infrastructure. Over the years, he has helped leading organizations design and implement secure, scalable solutions that drive innovation and long-term impact.

He leads Team8’s innovation strategy, driving new growth opportunities and working closely with founders to build category-leading companies. As well as contributing to Team8’s overall processes and needs, Israel has a particular interest in ideating and building groundbreaking companies in the Digital Health space.

Jessica is a full-stack marketer with over 12 years of marketing-for-tech experience. Jessica serves as product marketing manager at Team8 where she is responsible for overseeing the marketing strategy and execution for the group’s Digital Health Foundry and Digital Health portfolio companies. Throughout her career in the Israeli startup scene and in the tourism industry, Jessica has held numerous marketing roles across varied verticals.

Jonathan was part of the Sales Development team at Cato Networks, focusing on the Belgian market and targeting large enterprise accounts. He specialized in outbound initiatives and was consistently recognized as a top performer.

The Team8 advisor directory lists Judd Caplain with the external professional title Former Head of Global Financial Services. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

Julia is a Business Development Operations Specialist at Team8, where she supports portfolio companies in building and executing go-to-market strategies across digital health. She works closely with founders and leadership teams to drive targeted outreach, streamline operations, and accelerate growth.

Before joining Team8, Julietta worked for six years as a Bookkeeper at Zerto, and prior to that, she was part of the finance department at Union Motors Ltd.

The Team8 advisor directory lists Laizer Kornwasser with the external professional title Strategic Healthcare Advisor. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

The Team8 advisor directory lists Linda Hill with the external professional title Professor and Leadership Initiative Faculty Chair. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

The Team8 advisor directory lists Liran Amrany with the external professional title President. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

Maayan holds a BSc and MSc in Electrical Engineering, with expertise in machine learning and reinforcement learning. His deep theoretical foundation, combined with hands-on industry experience, bridges cutting-edge AI research and real-world applications.

The Team8 advisor directory lists Mariano Belinky with the external professional title Former Private Investor. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

A seasoned GTM executive, he has held senior roles at VMware and FireEye, as well as multiple VC-backed companies that achieved successful exits. With broad expertise in cybersecurity, he excels at driving organizations to build high-performing sales teams, instilling sales process discipline, and developing differentiated, prescriptive, and cohesive selling models, regardless of company stage.

Michael is a fintech analyst at Team8, where he leads research and analysis, contributing to the ideation, validation, and company-building process. Michael also provides strategic support for existing fintech portfolio companies. Prior to joining Team8, Michael was a consultant at KPMG Israel, where he specialized in fintech projects for major financial institutions in Israel. He is also a financial literary coach. Michael holds a B.A. in Economics and Business Administration from the Hebrew University of Jerusalem.

Michelle is the Head of IR and oversees capital development across all Team8 funds. She has nearly 20 years of experience in the financial industry managing investor relationships, legal negotiations, and helping to structure financial vehicles.

Mor brings a strong operational background and extensive experience supporting fast-paced teams. Over the past several years, she worked at Leal Health, an AI-powered healthcare platform, where she was deeply involved in day-to-day operations, internal coordination, onboarding, and process improvement- helping create structure, clarity, and a positive working environment.

Natali is a bookkeeper at Team8. Previously, Natali worked at Biscience, a startup company and Leo Schachter Diamonds. Natali holds a B.A in Mathematics from the University of Kazakhstan and Type 3 in Bookkeeping in Israel.

He brings extensive strategic and business expertise from his three years as a strategy consultant at Shaldor, leading projects for private and public sectors and advising C-level executives.

Nitay co-founded ActionIQ, the enterprise Customer Data Platform (CDP) that pioneered a new category in marketing technology. As CTO, he architected the platform end-to-end, scaled the company from inception to hundreds of employees, and helped grow it into a category leader serving Fortune 500 clients. ActionIQ raised $145M from Sequoia Capital and Andreessen Horowitz (a16z) and was acquired in 2025.

With a background as an Occupational Therapist in the pediatric rehabilitation department at Sheba Hospital, Nitzan dedicated her career to helping individuals overcome challenges and reach their potential. Now, She’s made a shift to bring that same commitment to supporting people in the workplace here at Team8.

Before joining Team8, Noa served as a Chief of Staff to the CEO in a SaaS B2B fintech start-up, playing a focal role in ensuring the smooth running of the organization towards achieving its strategic goals and objectives, working with the executive leadership team to develop and implement strategic business initiatives. Prior to that, she was an Operations Manager at a Single-Family Office where she oversaw the day-to-day operations and managed investment execution across various legal structures, coordinating multiple teams and stakeholders.

Noa Zamir is the Payroll Specialist at Team8. For the past 2.5 years, She has worked as a payroll expert at Guberman Consulting with approximately 25 companies per month, taking care of all their payroll needs. Noa holds a bachelor’s degree in sociology and East Asia studies from Tel-Aviv University. She spent 8 months in China teaching kids English, touring the country, and practicing her Chinese. In her spare time, she enjoys traveling, puzzle solving, and making desserts as a reminder of her past as a pastry chef.

Noam joins Team8 from Alice (formerly ActiveFence), where she served as Director of Brand Strategy and Engagement for nearly four years. In that role, she led the company’s brand strategy and engagement efforts, including its recent rebranding. Prior to Alice, Noam was a media advisor at BBDO and served for over seven years in the IDF Spokesperson’s Unit, primarily as an officer.

Noam brings with her a unique combination of experience in both administration and recruitment. She spent nine years at the Ministry of Defense as an Executive Assistant to senior officials, a role that demanded discretion, agility, and the ability to manage complex workflows. In recent years, she transitioned into recruitment, with a focus on analytical roles, and is now excited to return to the EA position she’s passionate about.

Prior to joining Team8, she worked at the Bank of New York (BNY), contributing to the firm’s rapid transformation, including roles in strategy and product innovation. She holds a BA in Economics from the University of Pennsylvania.

Nufar is Team8’s VP of Operations. Her mission is to support the growth of Team8 by implementing working models and adoption of new tools. She focuses on real estate, operations, community and welfare, that’s in order to empower the cross functional teams.

The Team8 advisor directory lists Omri Dahan with the external professional title Former CRO. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

Before joining Team8, Ori was the CRO and a founding member of Own (acquired by Salesforce). Under his leadership, Own’s ARR grew over 100% year over year to more than $170M and over 800 employees. He led a variety of functions including sales, customer success, sales development, operations, and alliances. Prior to this, he worked at Boston-based OpenView Venture Partners on a variety of go-to-market initiatives, including two years on Intronis (acquired by Barracuda Networks).

Before joining Team8, Oron worked as a manager at Ernst & Young Strategy and Transactions department, where he led financial and accounting due diligence processes for leading VC’s, PE’s and strategic corporate buyers in cross-border M&A and investment transactions.

Peleg is part of the venture creation team at Team8, where he works with founders and venture teams to turn deep technical ideas into sharp positioning, market narratives, and go-to-market strategy across cybersecurity and software infrastructure.

Reut brings significant experience in Healthcare and over 5 years of experience in data analysis to the team. She previously worked at Precision Advisors in London, where she specialized in life science regulations, market access, and pricing. Before moving to London, she worked at the Prime Minister’s Office as a data analyst. Reut holds a BSc in Biology and Biotechnology from Tel Aviv University and an MSc in International Health Policy from the London School of Economics (LSE).

Rinat has extensive experience in global financial management. In her previous role as Director of Finance at Yotpo, she led a team of 14 and successfully managed complex financial landscapes across multiple jurisdictions.

Before joining Team8, Ronen co-founded eToro, a financial unicorn that serves 31M users in more than 100 countries and has pioneered a social investing model. He served as the company’s Chief Product Officer and managed product and engineering, and since January 2020, has been a board member and non-executive director. Prior to this, Ronen designed products ranging from medical devices and household appliances to numerous desktop and web applications.

He is responsible for Team8’s Platform, an essential part of our unique venture fund model that means our team work to develop, sell, hire for, and expand our portfolio companies’ businesses, driving their success.

The Team8 advisor directory lists Rupert Keeley with the external professional title Former PayPal Europe CEO. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

Ruthie has joined us from Made Finance, where she worked for the last 8 years as Head of VC financial services. At Made Finance, she managed to help entrepreneurs to build and grow successful funds by providing the financial and operational expertise necessary to achieve their goals. Prior to that, Ruthie worked as a Director of Finance at SZ Accounting & Financial Consulting firm. Ruthie holds a B.A. in Accounting & Finance from the Hebrew University of Jerusalem.

She has held CEO, CFO, chairperson, and board member roles for multiple hi-tech companies, and has more than 26 years of investment and operational experience across Silicon Valley, New York, and Tel Aviv.

Sharon brings strategic and business experience from her two years as a consultant at Shaldor, where she advised numerous government agencies (e.g., the MoJ and PMO) and large private enterprises on growth and M&A strategies. Additionally, Sharon interned as a public sector strategy advisor at EY, where she closely supported the MoE in an education reform. She holds a BA in PPE from Tel Aviv University.

Before Team8, Shirly worked for 5 years as a Strategy Manager at Deloitte, leading consulting projects for private and public sectors and advising C-level executives. Before that, Shirly worked as a Data Analyst at the Israeli Ministry of Finance. Shirly began her career as an Intelligence Platoon Leader in the 8200 Unit and holds a B.A in P.P.E. (Philosophy, Politics, and Economics) from the Hebrew University of Jerusalem.

then spent three years at JPMorgan Chase as a VP of Product in the global blockchain team, where he led the development of real-life financial use cases for the bank. Most recently, he founded and ran

Before joining Team8, Tal served as a Brand Manager for Vulcan Cyber, a Tel Aviv-based cybersecurity startup, where she played a key role in shaping the company’s brand and positioning its platform as a leader in exposure and vulnerability management for enterprises.

Before joining Team8, Tamar worked as a Business Development Coordinator in the Agtech sector at the Israel Export Institute. Tamar holds a B.A. in Government and Sustainability from Reichman University, and while completing her studies, she spent two years working at the Foreign Ministry’s Asia and Pacific Division.

Before joining Team8, she held roles at DocuSign, Bringg, JFrog, and most recently led marketing at Sightfull. She is passionate about using AI, analytics and automation to streamline operations and accelerate pipeline generation.

Previously, he served as Chief Information Security Officer at SolarWinds, having joined the company in 2017 as Vice President of Security before stepping into the CISO role where he oversaw

The Team8 advisor directory lists Tomer Barel with the external professional title President. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

Tomer is a technology leader with deep experience in research and software development. Before joining us, he spent five years at Paragon, where he served as Director of the iOS Division. In that role, he led a team of 30 developers and researchers, building advanced low-level intelligence tools and capabilities in collaboration with governmental agencies.

Uri is a veteran technology leader and startup founder with over two decades of experience in building and architecting innovative systems. His last startup, Spectral, was acquired by Check Point. Uri was the Co-Founder & Chief Architect at Spectral, a startup that empowers teams to develop and deploy secure software at scale. After the acquisition, Uri became the Principal Architect of Cloud Security at Check Point, where he led the research and technology strategy for the cloud division.

Prior to joining Team8, Varda co-founded and served as the Chief Medical Officer of Alike. Health. As Founder and CEO of Maccabi’s Institute for Research and Innovation KSM, she established the first medical informatics program in Israel and pioneered its computerized medical and registry systems.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi

The Team8 advisor directory lists Vicky Bindra with the external professional title CEO. This is an advisory relationship to Team8, rather than that corporate job title at Team8.

Team8’s Talent Acquisition Manager. Her mission is to find the best talents to create and build Team8’s new cybersecurity, data science, fintech and Digital health companies.Formerly Talent Acquisition Specialist at Peacn.ai.

She currently lives in Hod Hasharon, is married to Benji, and is the proud mother of a 3-year-old son, Lavi. Her hobbies include attending children’s performances and visiting play centers.

Yael brings 5 years of experience as an office manager at a boutique law firm, where she developed excellent operational skills and a deep understanding of office and personal management.

He is an experienced investor who provides strategic business leadership and guidance to the fund and its portfolio companies, and serves as a board member to a large number of businesses.

Previously, he founded Payoneer, serving as its CEO and President. Before this, he co-founded Borderfree (NASDAQ: BRDR), a service provider that expedites cross-border ecommerce and payments for many large online and offline retailers, and was its CEO from 1999–2005. Yuval also served as VP of Business Development for Radware (NASDAQ: RDWR).

Adina Safer is a seasoned healthcare strategist and creator of The Medicaid Sessions. Her expertise in digital health and Medicaid enables her to develop innovative healthcare solutions. Safer’s unique value lies in her ability to create engaging educational content and strategies for healthcare improvement. Advisor to Reach Capital focused on healthcare strategy, Medicaid and digital health. She created The Medicaid Sessions and works on healthcare educational content and strategy. Her outside affiliations are context for the advisory role, not Reach employment.

Born and raised in the Bay Area, Amanda developed an early love for math, history, and art while attending public school, a combination that nurtured both her analytical and creative thinking. After earning a degree in marketing, she began her career in sales—a brief and unfulfilling chapter that ultimately led her to discover her true calling in venture capital while pursuing her MBA in 2007. Head of Investor Relations at Reach Capital, supporting relationships with limited partners. Her background includes marketing, communications and venture fundraising. She began pursuing venture-capital work while earning an MBA in2007.

Arjun Singh is CEO and Co-founder of Superconductor. He is also the Co-founder and former CEO of Gradescope, which was acquired by Turnitin, where he later served as Chief Strategy Officer. He holds a Ph.D in Computer Science from UC Berkeley where he taught artificial intelligence. Advisor to Reach Capital. He co-founded Gradescope, subsequently acquired by Turnitin, and later served as Turnitin’s Chief Strategy Officer. His current biography identifies him as CEO and co-founder of Superconductor. He earned a Berkeley computer-science doctorate and taught artificial intelligence.

Principal at Reach Capital focused on healthcare opportunities. She studied applied and computational mathematics and statistics at the University of Notre Dame, worked in investment banking at Bank of America and invested in growth-stage companies at Adams Street Partners before Reach.

Chuck joined MassMutual Ventures in 2015 and is charged with sourcing new investment opportunities and portfolio management. Recently, Chuck was promoted to partner, and as an expansion of his role, has joined our Climate Tech Fund. He brings his decade of venture experience within fintech and enterprises SaaS to the fund, and will look to source opportunities within climate insurance, carbon finance, and the blue economy, among others.

Christine joined the team in the fall of 2015 as MMV's Executive Liaison. She is responsible for managing daily operations, which includes onboarding new hires, invoicing, and fully supporting the US's three managing directors. Previously, Christine served as Executive Assistant for senior executives at McKinsey & Company, The Parthenon Group, EY, and Bain Capital. She holds a BS from Eastern Nazarene College. On her down time, Christine spends time with family and friends. She is an avid sailor who enjoys cruising the New England coastline.

David Landman is a former Global Head of Talent Development at Goldman Sachs and currently an HR Executive and startup advisor. His experience in talent development positions him as a leader in enhancing organizational capabilities. Landman’s unique value lies in his ability to advise startups and drive talent growth strategies. Advisor to Reach Capital and a human-resources executive with experience in talent development. Formerly Global Head of Talent Development at Goldman Sachs, he supports startups and advises on workforce capabilities.

Dehong was born in China and immigrated to San Francisco at the age of 12. His academic journey was challenging, marked by nearly dropping out of high school due to language barriers and a three-year pause to serve in the military. Despite these obstacles, he persevered and graduated from Golden Gate University with a Master’s in Accountancy, becoming the first member of his family to earn a college degree. Controller at Reach Capital. He earned a master’s degree in accountancy at Golden Gate University and previously worked as Assistant Controller at Lateral Investment Management, Senior Finance Manager at True Capital Management and Senior Audit Associate at RSM US.

Doug has served as Managing Partner and Head of MassMutual Ventures since its formation in July 2014. He joined MassMutual in 2007 as Senior Vice President and Chief Financial Officer for the Retirement Income business unit. From 2009 through 2016, he served as the company’s Senior Vice President of Strategy and Corporate Development.

Dr. Hannah Galvin is the Chief Health Information Officer and interim Chief of Pediatrics at Cambridge Health Alliance, and holds faculty appointments at Harvard Medical School and Tufts University School of Medicine. A nationally recognized leader in clinical informatics, she co-founded the equitable interoperability task force Shift, serves on the federal Health IT Advisory Committee, and champions patient-driven data sharing. Her focus on adolescent health, child abuse medicine, and vulnerable communities underscores her commitment to delivering equitable, patient-centered care. Advisor to Reach Capital and a physician focused on clinical informatics and adolescent health. Her published biography identifies leadership at Cambridge Health Alliance and faculty affiliations with Harvard and Tufts. Her work includes equitable interoperability and patient-driven health-data sharing.

Born in Buenos Aires, Esteban came to the U.S. at 18 for college and never left. After a few years in Wall Street and private equity, he fell in love with entrepreneurship while managing a pre-seed fund for Latin American startups, inspired by founders he worked alongside with, including those of Patagon (acquired by Santander Bank) and Mercado Libre (NASDAQ: MELI). He later co-founded two gaming startups that pioneered the game development industry in Latin America. Both were acquired — one by Activision and the other by DeNA of Japan. Co-founder and Partner of Reach Capital, which he helped establish in2015. Previously an entrepreneur in Latin American game development, he co-founded two gaming businesses acquired by Activision and DeNA. His current investment focus includes AI’s effect on work and labor.

Gordon Trujillo is the VP, Head of Learning and Development at DaVita Kidney Care. His experience in L&D positions him as a leader in creating effective learning programs. Trujillo’s unique value lies in his ability to develop and implement learning strategies that enhance organizational performance. Advisor to Reach Capital with expertise in workforce learning and development. His biography describes leadership of learning and development at DaVita Kidney Care and experience designing programs that support organizational performance.

Guillermo Miranda is a former Chief Learning Officer at Boeing and IBM, now co-founder of Atlas Copilot. He specializes in learning and development, leveraging his experience to drive innovation in corporate settings. Miranda’s unique value lies in his ability to create impactful learning platforms. Advisor to Reach Capital. His background includes chief learning officer roles at Boeing and IBM and co-founding Atlas Copilot. He focuses on corporate learning platforms and organizational development.

Senior Associate at Reach Capital. Previously an AI software engineer and product manager at Google, he spent six years building AI features across Search and Android. He applies technical and product experience to companies developing new operating models and tools for work.

Office Manager at Reach Capital. She studied advertising and women and gender studies at the University of Oregon, began her career as an art director in New York and subsequently moved into office management and event planning.

The son of a Marine-turned-cop dad and stay-at-home mom, James grew up in LA’s public magnet programs, finding his tribe among hardcore science and tech nerds. His love of STEM — for both its elegance and its power to improve lives — was forged during those years: stargazing from his backyard, interning at the LASD/LAPD crime lab, running a hand-coded anime file server off his laptop for otaku friends around the world. Partner at Reach Capital. He studied astrophysics at Yale, taught high-school mathematics through Teach For America and worked in college access and Yale admissions. After earning Stanford graduate degrees in business and education, he joined Reach to support technology founders. This investor is distinct from the existing Jona engineer and Arboretum Ventures associate with the same name.

Co-founder and Partner of Reach Capital. Previously a public-school history teacher for seven years, she earned a Stanford education master’s degree and spent nearly a decade developing venture-investment experience before founding Reach. Her investment interests connect learning technology with access to opportunity.

Jim is an accidental entrepreneur and an even more accidental investor. After graduating from Stanford, he was driven to make a difference in the world and took to being a public high school teacher. His classroom was a lively, noisy testament to the power of hands-on learning, which he later codified as History Alive! when he co-founded Teachers’ Curriculum Institute, which he operated for 16 years. Two subsequent education startups later, he joined Reach as a venture partner to help like-minded founders pursue their mission. Venture Partner at Reach Capital. A Stanford graduate and former public high-school teacher, he co-founded Teachers’ Curriculum Institute and developed its History Alive curriculum. He operated that business for sixteen years and subsequently built other education companies before becoming a venture partner.

Growing up in Orlando, Florida, Jomayra saw firsthand how access — or lack thereof — can shape the opportunities people have in life. That experience sparked a lifelong commitment to expanding opportunity for others. Partner at Reach Capital focused on healthcare and work. Her prior experience includes product and customer roles at BloomBoard and venture investing at Emerson Collective and Cowboy Ventures. Her current biography names work with Stepful, WorkWhile and Manifold. She studied political science and education at Stanford and works from New York.

Josh was born and raised in a small town in upstate New York. Moving from that small town to a career in public accounting (Deloitte) in the Bay Area gave him insights into a whole new world of ambition and the amazing people trying to make the world a better, more interesting place to live. He found his professional calling when auditing one of his first clients, a prominent VC firm, recognizing it as a critical engine for building and scaling new ideas. Chief Financial Officer of Reach Capital. His career includes auditing venture, private and public companies at Deloitte, ten years at Venrock beginning in2013, and serving as CFO and CCO at Contrary. At Reach he supports finance operations and fund strategy.

Julia Bernstein serves as the Chief Operations Officer at Brightside Health, where she leads strategy and operations to expand the company’s virtual mental health care services. With extensive experience in behavioral and digital health, she has a background in payer sales, startup operations, and nonprofit strategy. Bernstein’s unique value lies in her ability to scale healthcare operations and drive growth in critical areas like mental health. Advisor to Reach Capital with experience in behavioral and digital-health operations. Her biography describes leading strategy and operations at Brightside Health and prior work in payer sales, startup operations and nonprofit strategy.

Kara Burns is a Senior Associate with the Climate Technology Fund. Kara started her career in Fidelity’s equity research department. Most recently, she was a Sector Specialist on the private placements team, Fidelity’s late-stage VC and cross over investing arm, where she contributed to recommendations representing over $1B in capital deployed. Prior to this, she worked on the ESG, consumer, and strategic advisors teams.

Maria is a passionate advocate for the belief that education, socioeconomic mobility, and excellent health are the most powerful tools for universal opportunity. As a dedicated team member, she is known for her exceptional customer service, consistently going above and beyond to welcome and support everyone who interacts with Reach. Administrative team member at Reach Capital. Her published biography describes customer-service and hospitality work supporting founders, visitors and the firm’s community. She advocates for access to education, health and socioeconomic opportunity.

Prakash is a physician-operator with experience spanning clinical training, startup formation, and large-scale healthcare leadership. He trained in orthopedic surgery before helping spin out a half-dozen pharma and device companies, then spent years running major health organizations. At GuideWell he served as COO and President, helping scale the company past $20B in revenue. At Elevance (formerly Anthem), he grew the Diversified Business Group 6X in three years and led a behavioral health transformation from under 1% digital to over 30%. Advisor to Reach Capital and a physician-operator with experience in company formation, payer operations and specialty care. His biography describes prior leadership at GuideWell and Elevance and an interest in value-based chronic-condition care. The directory’s external employer captions are not treated as Reach executive titles.

Advisor to Reach Capital with three decades of academic health-system experience. His published biography describes leadership at Stanford Medicine Children’s Health and prior operations roles at Women & Infants Hospital, St.Louis Children’s Hospital and Barnes-Jewish Hospital. He supports founders working in pediatric, women’s and hospital care.

Rob Purinton is the Chief AI Officer at AdventHealth. His experience in AI and healthcare positions him as a leader in leveraging technology to improve healthcare outcomes. Purinton’s unique value lies in his ability to develop and implement AI-driven healthcare solutions. Advisor to Reach Capital with expertise in healthcare artificial intelligence. His published biography identifies him as Chief AI Officer at AdventHealth, supporting development and implementation of healthcare AI solutions. This outside-employer title is not treated as a Reach officer role.

From a young age, Shauntel understood the transformative power of education. From her time at MIT studying chemical engineering to completing her MBA and MA in Education at Stanford, she’s navigated life with a curious mind and an insatiable appetite for knowledge. Shauntel set out to instill this same love for learning in others through volunteer tutoring and mentoring programs. She is also a health enthusiast and understands that a healthy mind and body are essential for learning and thriving. Co-Founder Emeritus of Reach Capital, as explicitly designated by the current directory. She studied chemical engineering at MIT and earned Stanford graduate degrees in business and education. Her prior Reach investment work supported learning and health companies. The emeritus designation does not imply a current active partner role.

Steve has spent his career at the intersection of education, health, and policy, supporting founders and school systems through periods of major transition. He’s led software implementations in large urban school districts, including the first digital special education platform in post-Katrina New Orleans. Influenced by the impact of strong public leadership, he spent several years recruiting and training hundreds of school superintendents in the critical areas of board governance, collective bargaining, political mapping, media relations, community engagement, and bond measure strategy. Partner at Reach Capital with experience in education, healthcare and public policy. His work includes software implementation in school districts and training school-system leaders. Before Reach, he was an operating partner on Vistria Group’s Knowledge and Learning team. Earlier investments are not automatically attributed to Reach.

Stuart brings more than two decades of engineering and product leadership experience. Most recently, he was Chief Technology Officer at One Medical, where he led the technology organization through rapid growth, IPO, the acquisition of Iora Health, and integration into Amazon. Before that, he co-founded Rise, a digital health startup offering personalized coaching, which became One Medical’s first acquisition. Earlier in his career, Stuart helped shape the early internet at Mozilla and Netscape. Advisor to Reach Capital with engineering and product-leadership experience. He formerly led technology at One Medical through its IPO, Iora Health acquisition and Amazon integration. Earlier he co-founded digital-health coaching company Rise and worked at Mozilla and Netscape.

Tim joined MassMutual Ventures as Managing Partner in 2023 and leads the Climate Technology Fund. Prior to MMV, he was a Managing Director at Equinor Ventures and served on the boards of several portfolio companies, including Commonwealth Fusion Systems, Mainspring, SkySpecs, and Sunverge. His previous positions at Equinor included CEO Advisor, Corporate Strategy Manager, and Business Development Manager. Earlier in his career, Tim held research and consulting roles at Cambridge Energy Research Associates (now part of S&P Global), the Oxford Institute for Energy Studies, and Google.

Born in Hong Kong and raised in Los Angeles, Tony thought that simply doing well in school would equate to doing well in life. That was true up to a certain extent, until he tried academia and realized it wasn’t quite the right environment for his more creative aspirations. Head of Platform at Reach Capital. His founder experience includes an education mathematics game and education-technology journalism outlet EdSurge. At Reach he supports early-stage founders and shares practical experience through the firm’s research and communications.

From reading Magic Treehouse books as a child to learning about different cultures in person, Valentina loves exploring. She was born in Colombia and raised in Florida, navigating two cultures and a new education system. Learning to access new opportunities shaped her view on accessibility and inspired her to create positive social and environmental change. Marketing Associate at Reach Capital. She studied at the University of Southern California’s Iovine and Young Academy, combining design, technology and entrepreneurship with an interest in social entrepreneurship and human-centered design.

Co-founder and Partner of Reach Capital. She began working at NewSchools Venture Fund in2005 alongside the other founding partners, developing experience in education entrepreneurship and technology. She supports early-stage founders building tools for learning, health and work.

Born in Hong Kong and raised in San Francisco, Winnie has called the Bay Area home her entire life. Her roots in the city have shaped her appreciation for innovation and community values. Administrative team member at Reach Capital. Her biography describes a career as an executive assistant in venture capital, supporting investment teams and the people building new companies. The current directory uses the title Admin; an investment role is not inferred.

Designer at Reach Capital. She studied communication design, psychology and human-computer interaction at Washington University in St.Louis and worked as a research assistant in attention/performance and sensory-interface laboratories. Her design interests connect research on perception with human interaction.

Issuer September 2025 identifies Missy as co-founder and advisor, previously at Google, Amazon, federal health agencies and Canvas Ventures. This advisory position is distinct from full-time employment; current tenure not reconfirmed.

Issuer September 2025 names Srini Rudraraju as founding-team engineering leader, previously at UnitedHealth Group and Dell. Linked profile identifies Srinivas Raju Rudraraju. Current tenure not reconfirmed.

Issuer September 2025 names Vamsi as a founding-team member and technical implementation leader, previously at UnitedHealth Group and ADP. Current tenure not reconfirmed.

Issuer September 2025 names Mike Espy as a healthcare technology sales executive. Current tenure not reconfirmed.

Issuer September 2025 names Terry as Head of Partnerships, previously at Pager, Oura, Blue Spark Technologies and Salesforce. Current tenure not reconfirmed.

Previously healthcare CIO at Capital BlueCross and Optum; issuer September 2025 states he first invested personally, then advised and joined as CSO. Current tenure not reconfirmed.

Julian Gutierrez is named in the current Penguin Ai author directory.

Glenn Herzberg is named in the current Penguin Ai author directory.

Jake is an engineering leader with more than five years in senior roles at AI/ML companies and a longer history of executive leadership across Bay Area startups. He was most recently VP of Engineering at AMESA, a platform that lets non-programmers train deep reinforcement learning models on their own expert skill sets, and earlier led several engineering and QA teams at Amazon Music. His recent work centers on using AI coding tools to raise the quality and efficiency of the code they produce, and on building strong AI products without runaway token costs.

Nate is a healthcare revenue leader with more than 15 years building and scaling commercial organizations, most recently as Chief Strategy Officer at Surgical Information Systems. He previously held senior sales leadership roles at Surgical Notes, Intelligent Medical Objects, iMedX, and Ingenious Med, spanning revenue cycle management, clinical terminology, and EMR/PM technology.

Dan is a healthcare product leader with 20+ years building and commercializing technology across payer, provider, and digital health markets, with senior roles at RevelAi Health, Best Buy Health, Clinicient, Philips Healthcare, and Intellectual Ventures. He holds an MBA and an MS in Biomedical Engineering from the University of Washington, along with a BSE in Biomedical Engineering.

Abigail is a healthcare strategy and operations leader with experience spanning commercial strategy, revenue operations, and technology across payer, provider, and digital health markets, most recently leading Technology Strategy at SCAN Health Plan. She previously led Healthcare Commercial Strategy at Afiniti and held earlier roles at Kaiser Permanente's Transformation Office and Accenture's Digital Strategy Practice, building expertise across healthcare delivery and strategic consulting.

Niki is a practicing family physician with nearly two decades of primary care experience, a Stanford-trained data scientist and MBA, and a former health plan Chief Medical Officer who has worked at the intersection of clinical care, AI, and operations. She has also served as Corporate Medical Director at the Cleveland Clinic and as an advisor to organizations including Creative Destruction Lab, AltaML, and Elevance Health.

Kishore is a hands-on AI leader who built AI capabilities across Risk and Quality, Care Management, Utilization Management, and OptumRx at UnitedHealth Group, generating $250M in annual savings and incremental revenue, with earlier roles at Amazon and American Express. He holds 10 patents at the intersection of AI, healthcare, and operations, has authored five books on machine learning and AI, and holds an MBA from the Indian Institute of Management, Calcutta.

Penguin Ai Corp. is a Palo Alto healthcare artificial intelligence company founded in early 2024. It develops an operating system for healthcare administration, combining data integration, governed contextual reasoning, task-specific language models and AI Workers for payers, providers and revenue-cycle organizations. Published workflows include prior authorization, utilization management, medical coding, risk adjustment, claims processing, appeals and payment integrity. Its Gwen product lets customers build governed AI Workers. The company describes auditable recommendations, permissions and human oversight; these are administrative platform capabilities, not a verified regulatory approval or claim that the platform independently diagnoses patients. The current public leadership roster lists Fawad Butt, Kishore Ayyadevara, Niki Panich, Abigail Crenshaw, Dan Wu, Nate Kiely and Jake Reichert. Its author directory additionally names Glenn Herzberg and Julian Gutierrez. Earlier executive and founding-team roles announced in 2025 are retained with their source period rather than assumed to remain current. Penguin Ai announced a USD 25M Series A led by Greycroft on September 11,2025 within USD 29.7M of cumulative venture funding. The cumulative figure is not an additional round, and the undisclosed2024 seed amount is not calculated by subtraction. CHCF separately reports USD 400K in June 2025 and USD 100K in November 2025 as program-related investments; their instrument and overlap with the Series A are not disclosed. This healthcare company at penguinai.co is distinct from the closed penguinai.app sales-software business, Penguin Solutions and Penguin Random House.

Fawad spent more than a decade running the largest data and analytics organizations in American healthcare, serving as Chief Data Officer at Kaiser Permanente, UnitedHealthcare, and Optum, where his teams supported care for over 60 million members. He was previously Executive-in-Residence at Canvas Ventures, where he helped lead the firm's healthcare AI thesis, and holds an MBA from Northwestern's Kellogg School of Management.

Ihsaan Patel is identified as a Readily co-founder in Y Combinator’s August2024 healthcare-compliance product launch and his own August29,2024 launch announcement alongside Edward Tiong. Those primary posts establish a historical founder affiliation, while Readily’s current YC active-founder directory names Edward Tiong and Wei An Wang. His current operating role, departure date and an exact historical CEO appointment are not established by the reviewed sources.

Ali Mirza joined Careforce AI according to founder Huzaifa Sial’s public announcement linking his exact professional profile. That profile lists Wilfrid Laurier University studies and quantitative projects involving statistical modeling and simulation. Older ResourceMill affiliation remains historical context; his exact Careforce responsibilities and appointment day are not disclosed.

Haris Imran is publicly named by founder Huzaifa Sial among new Careforce AI team members. The announcement links his exact professional profile and establishes the affiliation. His specific responsibilities, educational background and appointment day are not disclosed in the accessible primary announcement; unrelated Haris Imran profiles are not merged.

Pegah Jahankhah joined Careforce AI according to founder Huzaifa Sial’s public team announcement. Her own public posts discuss healthcare product research and personalized patient journeys that connect data with useful next actions. Older profile headers still name Jack Health; the newer employer announcement establishes the Careforce appointment without inventing an exact job title or start day.

Salman Tariq is publicly identified by founder Huzaifa Sial as a Careforce AI team member working with Kern Family Health Care on data integration and patient-support workflows. The company also features him explaining AI-agent execution in healthcare. His precise formal title is not disclosed in the accessible primary company sources.

Shafkat Haque contributes to Careforce AI’s design and agent-experience work. The company publicly features him explaining how AI coworkers interact with healthcare teams, and founder Huzaifa Sial credits his work bringing Angelica and David to life. His own website describes more than a decade of design and engineering experience at Apple, BlackBerry and other organizations. A collaborator role is recorded without asserting undisclosed employment terms.

Usama Sha, referred to as Usama Shah in a founder recommendation, supports Careforce AI through BrandingWaves as a marketing manager and content creator. Founder Huzaifa Sial describes his work across social media, blog content, podcasts and AI-agent videos. His self-published profile describes more than seven years of marketing experience. This is explicitly an external marketing collaboration rather than an inferred full-time employee appointment.

Benjamin Dykstra publicly lists Careforce, previously Helpcare AI, as his current professional affiliation. His own profile lists College of William and Mary studies from 2013 to 2017. The company’s own public employee directory corroborates this affiliation; his precise job title is not exposed.

Mahesh Sundaram is a software engineer working at Careforce AI. His own profile describes building human-AI collaboration and lists Arizona State University education. Founder Huzaifa Sial independently names him among the Careforce team visiting healthcare partners. His prior technical recommendations describe frontend and full-stack development, but an exact current employer title is not exposed.

Manuel Pedroza leads technology strategy and growth at Careforce AI. His own company appointment announcement describes nearly 15 years in community-health and federally qualified health center leadership. He previously led information technology at Clinica Sierra Vista and holds CHIME healthcare CIO and digital-health executive certifications. His historical employer page and award portrait describe his earlier affiliation; the current Careforce appointment takes precedence.

Mike Miller publicly lists Careforce as his current professional affiliation and University of Waterloo education. Founder Huzaifa Sial names him among the Careforce staff working with Kern Family Health Care on data integration and broader patient-support workflows. His exact formal job title is not exposed in the accessible primary profile.

Huzaifa Sial is the founder and chief executive officer of Careforce AI. He previously led healthcare AI work at UnitedHealth and Optum and has more than 14 years of experience developing disease-prediction, patient-engagement and care-delivery software. His public accelerator biography lists a master’s degree in clinical informatics from Northwestern University, four healthcare AI patents and two prior healthcare AI exits.

Careforce AI is a California healthcare software company, legally Helpcare AI, Inc., that builds AI agents for care coordination and administrative workflows. Its Angelica care-coordination agent contacts patients through voice and other channels for scheduling, reminders, referrals, screenings and Medicaid eligibility renewal; its David data agent works across healthcare portals and records to identify patients and coordinate tasks. The software supports health plans, community health centers and other providers, with administrative exceptions and follow-up handled by human staff. Founded in 2024 by CEO Huzaifa Sial, Careforce joined Y Combinator’s Fall 2024 batch. Its current legal footer gives an Alameda address, while its public accelerator and employer profiles identify the San Francisco Bay Area. California Health Care Foundation reports a USD500,000 program-related investment in February 2026 to support care access across the Medi-Cal delivery system. This is distinct from client contracts and adoption metrics. Careforce is relevant to AI agents, healthcare software and workflow automation; it is not represented as an autonomous diagnostic medical device or a neuroscience treatment. The company is distinct from Careforce GmbH, CareForce Cloud and the getcareforce.com clinic-services business.

Christopher Martin is published by Alto Neuroscience as Vice President, CMC Operations in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Jill Sniffen is published by Alto Neuroscience as Vice President, Clinical Operations in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Melissa Berman is published by Alto Neuroscience as Vice President, Finance and Accounting, and Controller in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Michelle Moran is published by Alto Neuroscience as Vice President, Quality Assurance in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Patricio O’Donnell is published by Alto Neuroscience as Vice President, Translational Medicine in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Jonathon Parker is published by Alto Neuroscience as Senior Vice President, Head of Regulatory Affairs in its May2026 corporate presentation. This affiliation concerns a clinical-stage precision psychiatry company using brain biomarkers and machine learning for drug development. The presentation provides an authentic named portrait; an expanded individual career biography and later appointment changes were not independently disclosed.

Managing partner at Healthworx, the healthcare investment platform originally launched within CareFirst. RAAPID’s April 2026 primary financing announcement identifies his managing-partner title and quotes him on the investment in healthcare AI and risk adjustment. The current Healthworx Ventures directory also publishes him as a team member.

Associate at Healthworx Ventures. The platform’s February 2026 promotion announcement describes her joining in summer 2024 after healthcare work at McKinsey. Her work spans investment theses, relationships with startups and healthcare stakeholders, and investment diligence.

Doba Parushev is a published member of the Healthworx Ventures team, which invests in healthcare companies. The current official team directory identifies the person by name and publishes an original portrait; a formal investment title and detailed professional biography are not disclosed in the accessible directory.

Managing director of Healthworx Ventures, as identified in the platform’s August 2025 interview with accelerator head Soo Jeon. Her earlier work included corporate venture capital and the 1501 Health healthcare accelerator; the current Ventures directory continues to name her among the team.

Emily Queen is New Ventures Lead at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Jaime Goff is New Ventures Manager at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Josh Brown is New Ventures Lead at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Katherine Martinko is Vice President, New Ventures at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Healthworx Ventures investor whose own introduction describes joining in August 2022 after work at the World Bank and a healthcare technology startup. She studied economics and international affairs at George Washington University and earned an MBA and an MS in Information Systems at the University of Maryland. Her published work covers healthcare innovation, including maternal health. Her 2022 senior-analyst title is historical; a current formal title is not disclosed in the accessible team directory.

Malav Patel is Vice President, Operations at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Mike Batista is Managing Partner at Healthworx Studio, the healthcare company-building branch of the Healthworx ecosystem. The studio publishes the person in its current operating team directory. This affiliation does not establish a general-partner appointment at Healthworx Ventures.

Nirban Singh is a published member of the Healthworx Ventures team, which invests in healthcare companies. The current official team directory identifies the person by name and publishes an original portrait; a formal investment title and detailed professional biography are not disclosed in the accessible directory.

Lightswitch Capital is a New York investment manager and long-term partner to private healthcare companies. Its legal adviser is Lightswitch Capital Management, L.P., a Delaware limited partnership reporting to the SEC as an exempt reporting adviser under CRD319223. Its healthcare investments include precision neuropsychiatry company Alto Neuroscience, gene therapy engineering company Kriya Therapeutics and antibody-platform company Hinge Bio. Current regulatory disclosures identify Christopher Nixon Cox as chief executive officer and general partner, Bo Cui as chief operating officer, and Pamela Louise Rockley as chief compliance officer. Rockley provides compliance services through her consulting business; she is included as a regulatory officer rather than an investment partner. The adviser reports one Cayman Islands private fund, Lightswitch Capital Fund I, L.P., with Lightswitch Capital GP, LLC as general partner. Public fund assets do not establish its final commitments or closing date. The firm is distinct from unrelated businesses using the Lightswitch name.

Bo Cui is chief operating officer of Lightswitch Capital Management, L.P., according to its current SEC adviser filing. His published biography describes experience in private equity and cross-border mergers and acquisitions, including senior roles at BrightSphere Investment Group and CCB International. He earned a law degree from Georgetown University Law Center and studied mathematics and computer science at the University of Illinois at Urbana-Champaign. His current issuer biography also identifies him as chief legal officer of High-Trend International Group.

Pamela Louise Rockley is the chief compliance officer of Lightswitch Capital Management, L.P., as confirmed by its March2026 SEC adviser filing. FINRA identifies her as president of Compliance Directives LLC, a compliance consulting business, and describes her compensated chief compliance and anti-money-laundering officer services for investment firms. Her Lightswitch affiliation is a regulatory and compliance role, rather than an investment-partner appointment. An authentic public portrait was not located.

Edward Tiong is Readily’s co-founder and CEO, confirmed by its Y Combinator and CHCF profiles. He studied AI at Berkeley and previously worked as a machine-learning engineer at AKASA and a data/applied scientist at Microsoft AI. CHCF describes his work on personalized Smart Reply for Outlook. YC describes him as a three-time founder and holder of two patents.

Wei An Wang is Readily’s co-founder and CTO, identified in its current Y Combinator company profile. His publicly published YC biography states that he is building in AI; a more detailed education or career history was not available in the reviewed primary sources.

Readily is a San Francisco healthcare-compliance AI company building a unified platform for regulatory research, policy management, delegation oversight and audits. It links requirements, policies, contracts, reports and case files, analyzes audit evidence, identifies policies affected by regulatory changes and drafts revisions for expert review. It serves health plans and providers, including Medi-Cal managed-care organizations. Reported time, cost and audit-coverage improvements are company and investor case-study claims, not independently verified clinical outcomes. Edward Tiong is co-founder and CEO, and Wei An Wang is co-founder and CTO; those are the two active founders named by Y Combinator. Its directory reports20 team members but does not name the full staff. CHCF reports a2023 founding and YC records Summer2023 participation, while YC’s current Founded field says2024; the inconsistent2024 field is retained as a source discrepancy rather than treated as a separate company or financing event. California Health Care Foundation reports a USD1million program-related investment awarded in June2026. Its exact day, security instrument, round stage, terms and disbursement status are not disclosed. The company explicitly names Y Combinator, Define Ventures and CHCF as backers; SUTD’s own Venture Innovation Fund also lists Readily in its portfolio, linking the former readily.co domain that now redirects to readily.ai. No standard accelerator ticket or undisclosed seed total is inferred. Readily is relevant to healthcare AI and regulatory automation; reviewed sources do not establish a neuroscience therapeutic or neural-interface business. It is distinct from Swedish Readily Diagnostics, government-service company Readyly, Read AI and Indian Readily Solutions. Y Combinator’s August2024 launch and Ihsaan Patel’s own launch post also identify Patel as a co-founder alongside Edward Tiong. That historical affiliation is retained separately from the current active-founder list; no current Patel CEO office or departure date is inferred.

Supports founders and builds the Boost VC community. Previously at 500 Startups and Altitude; holds a biology degree from Washington State University.

Finance leader and systems builder at Boost VC. Previously at Sydecar, On Deck and Juniper Square; Santa Clara University alumnus.

Scientist and strategist working in venture investing at Boost VC. Previously at Trinity Life Sciences, F-Prime Capital and Castle Island Ventures; Brown University alumnus.

Groove Quantum develops quantum processors built from germanium spin qubits. Its chips use compact qubits and CMOS-compatible semiconductor manufacturing to scale quantum computers through established chip foundries and supply chains. Founded by researchers from Delft’s QuTech ecosystem, the company designs, fabricates and integrates semiconductor quantum hardware.

QMatter develops quantum compression software that reduces complex molecular simulation problems to smaller computational representations while retaining their essential features. Its algorithms improve the performance of classical and quantum computers for life sciences, drug discovery and materials research. The company works with pharmaceutical and biotechnology businesses and develops physics-informed simulation datasets for training AI models.